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Abstract
The ability to perform effectively in the gastrointestinal system (GIT) is one of
the most significant criteria for selecting the best probiotic bacteria. Thus, the present
study aimed to investigate the potential probiotic characteristics of some selected lactic
acid bacteria (LAB) isolated from vegetable products. Probiotic characteristics included
tolerance to acid and bile, cholesterol removing ability, bile salt hydrolysis, resistance
against lysozyme and antibiotics, production of exopolysaccharides (EPS), antimicrobial
and hemolytic activities, and cell surface characteristics (auto-aggregation, coaggregation, and hydrophobicity). Out of 46 isolates, 17 isolates that exhibited
remarkable survivability under gastrointestinal conditions were selected for further
analysis. Almost all 17 isolates tolerated bile salts, while isolates F5 and F26 exhibited
the highest bile salt hydrolase activity. Isolates F1, F8, F23, and F37 were able to reduce
cholesterol in the broth. The auto-aggregation, the average rate increased significantly
after 24 h for all isolates, while 2 isolates showed the highest hydrophobicity values.
Moreover, all isolates showed high co-aggregation values after 24 h of incubation
compared to 4 h values. All isolates were resistant to lysozyme and vancomycin, and 8
out of the 17 selected isolates displayed an ability to produce EPS. Based on 16S rRNA
sequencing, LAB isolates were identified as Enterococcus faecium, E. durans, E. lactis,
and Pediococcus acidilactici

Keywords: Auto-aggregation, antimicrobial, cholesterol-lowering, immunomodulation.
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)Title and Abstract (in Arabic
دراسة الصفات الصحية لبكتيريا حمض اللبن المعزولة من الخضروات :الخصائص المحتملة للبكتيريا النافعة
ومابعد الحيوية بما في ذلك التأثيرات المناعية
الملخص

تُعد امكانية االداء الفعال في الجهاز الهضمي من أهم المعايير التي يتم من خاللها اختيار افضل بكتيريا
نافعة .تهدف هذي الدراسة إلى التعرف على الخصائص المحتملة لبعض البكتيريا المختارة من حمض الالكتيك
والتي تم عزلها من منتجات الخضروات .أظهرت الخصائص الحيوية للبكتيريا قدرتها على مقاومة األحماض والمادة
التي يفرزها الكبد ،والقدرة على إزالة الكولسترول ،والتحلل المائي ألمالح المرارة ،ومقاومة الليزوزيم والمضادات
الحيوية  ،وانتاج مخلفات السكر التي يتم افرازها بواسطة الكائنات الحية الدقيقة إلى البيئة المحيطة ،وأنشطة
مضادات الميكروبات ومحلالت الدم  ،وخصائص سطح الخلية (التجميع الذاتي  ،والتجمع المشترك  ،ومقاومة
للماء) .تم اختيار  17عينة معزولة أظهرت قدرتها الملحوظة على البقاء رغم ظروف الجهاز الهضمي من أصل 46
عينة لتخضع لمزيد من التحليل .معظم العينات المختارة تحملت أمالح المرارة ،بينما أظهرت عينات  F5و  F6أعلى
نشاط النزيم الهيدروالز ألمالح المرارة ،فيما بينت عينات  F1و  F8و  F23و  F37قدرتها على تقليل
الكورلسترول .زاد معدل التجميع التلقائي بشكل ملحوظ بعد  24ساعة لجميع العينات المعزولة ،في حين أظهرت
عينتين معزولتين أعلى قيم لمقاومة الماء .باإلضافة إلى ذلك ،جميع العينات المعزولة أظهرت قيم عالية للتجميع
البكتيري المشترك خالل  24ساعة من العزلة مقارنةً بقيم  4ساعات .أظهرت جميع العينات مقاومتها لليزوزيم
والفانكومايسين ،و  8عينات من أصل  17عينة مختارة أظهرت قدرتها على انتاج المواد البوليمرية خارج الخلية .تم
تحديد العينات المعزولة مختبريا ً بناءاً على تسلسل 16S rRNAعلى أنها Enterococcus faecium, E.
durans, E. lactis Pediococcus acidilactici
كلمات البحث الرئيسية :التجميع الذاتي ،مضاد الميكروبات ،خفض الكوليسترول ،التعديل المناعي.
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Chapter 1: Introduction
Probiotics are defined as “live microorganisms which, when administered in
adequate amounts, confer a health benefit on the host” (FAO/WHO, 2002). Based on the
definition, a microorganism is labeled as a probiotic only when there is scientific
evidence proving its potential health benefits for the host (Mack, 2005). The
International Scientific Association for Probiotics and Prebiotics (ISAPP) states that for
a microorganism to be described probiotic, it should first go through a series of human or
intended user trials to ensure safety, to prove at least one of the claimed health benefits
that the microorganism provides for the host (Hill et al., 2014). In general, the most
common microorganisms added to food products or supplements for their probiotic
abilities include members of lactic acid bacteria (LAB) and bifidobacteria (Ayyash et al.,
2021).
The capacity of bacteria to survive through the GI system, reach either the small
or large intestine in sufficient numbers and interact with and/or attach to and colonize the
host is the basis of adding probiotics to foods and supplements for their possible health
advantages (Ayyash et al., 2021). Several factors have a deleterious effect on probiotics,
including the stomach's high acidity (pH 1.5 – 3.0), bile salts, and digestive enzymes.
Additionally, prior to consumption, the probiotics must maintain viability throughout
culture manufacture and storage, product or supplement manufacture, and product shelflife (Ayyash et al., 2021).
In point of view, one of the observations stated that the secretion of various
metabolites, such as postbiotics, during the metabolic activity of microorganisms
possessed beneficial effects on the host (Żółkiewicz et al., 2020). However, postbiotic
precise definition is still under discussion but one study it is defined as and substance or
metabolite released or produced during the metabolic activity that offer health benefits
on the host (Tsilingiri & Rescigno, 2013). In addition, studies previewed that postbiotics
might strengthen the intestinal microbiota (Klemashevich et al., 2014).
Currently, there are several classes of postbiotic drugs whereas each have
different mechanism and provide different beneficial effect on the host. One type of the
metabolites released are cell-free supernatants which are biologically containing

1

metabolites secreted by microorganisms that shows different activity according to the
microorganism used. Indeed, Lactobacillus acidophilus and Lactobacillus casei released
supernatants that showed anti-inflammatory and antioxidant on the intestinal epithelial
cells that can reduce the risk of colon cancer (Żółkiewicz et al., 2020). Moreover,
supernatants liberated from Lactobacillus and Bifidobacterium showed antibacterial
activity against enterinvasive E. coli strains into enterocytes in vitro (Żółkiewicz et al.,
2020). In addition, during microorganism growth biopolymers with different chemical
properties are produced and released as exopolysaccharides outside the bacterial cell
wall which showed several beneficial properties such as antimicrobial and antioxidant
properties and showed great effect in inhibiting cholesterol absorption (Khalil et al.,
2018; Li et al., 2014). In terms of antitumor effect, Porpionibacterium freudenreichii
produce SCFA pronate that resulted in the apoptosis of gastric cancer cells (Cousin et al.,
2012). Furthermore, some postbiotics succeeded in reducing the risk of cardiovascular
disease as SCFA pronate plays a significant role in inhibiting the condensation of
cholesterol precursors (Bush & Milligan, 1971). Besides, several studies displayed the
therapeutic effect of postbiotic on allergic diseases by restoring the balance of Th1/Th2mediated immune response and enhancing the maturation of the immune system (de
Boer et al., 2020; Esposito et al., 2018).
Clinical studies have demonstrated various health effects of consumption of these
microorganisms, such as reduction in duration and occurrences of diarrhoea, alleviation
of symptoms of lactose intolerance, reduced incidences of pathogenic infection, and
stimulation of the immune system and regulation of the inflammatory response (de
Vrese, 2008; Hill et al., 2014). The present study aimed to investigate the potential
probiotic characteristics of some selected LAB isolated from vegetable products, i.e.,
tolerance to acid and bile, cholesterol removing ability, bile salt hydrolysis, resistance
against lysozyme and antibiotics, production of exopolysaccharides (EPS), antimicrobial
and hemolytic activities, and cell surface characteristics (auto-aggregation, coaggregation, and hydrophobicity).
Fruits and vegetables are one of the main dietary requirements in an adult’s diet,
and according to The Dietary Guidelines for Americans, it is recommended to consume
half section of the plate as fruits or vegetables in all-day meals (Slavin & Lloyd, 2012).
2

In terms of nutritional composition, fruits and vegetables are considered highly nutritious
foods as they provide high amounts of vitamins, such as vitamin C and A, minerals,
specifically electrolytes, and phytochemicals in specific antioxidants that fight free
radicals in the body (Slavin & Lloyd, 2012). In terms of the selection of the source of
probiotics, this study used fresh vegetables as a source of probiotics due to their
beneficial properties, nutritional value, flavor enhancement and reduced toxicity that is
granted from the process of lactic acid fermentation that is usually performed to increase
the shelf life of fresh fruits and vegetables. In addition, the low sugar content, enrich
mineral and vitamin content, and neutral pH enhance the process of LA fermentation.
Several studies showed the great health benefit offered from LAB that were isolated
from fresh vegetables. Indeed, studies proved that the consumption of LA fermented
vegetables and fruits provided balanced nutrition value in terms of vitamins, minerals,
and carbohydrates that plays a role in the prevention of several diseases such as diarrhea
and liver cirrhosis. Moreover, colored pigments found in some fruits and vegetables such
as flavonoids, lycopene, anthocyanin, β- carotene, and glycosylates acts as antioxidants
that fights free radicals that might result in reducing the risk of several disease such as
cancer, arthritis, and ageing. However, the current study aimed to isolate LAB from
fruits and vegetables, describe, and discover new probiotics with different properties,
including 1) gastrointestinal. Tolerance by a) in-vitro digestion, b) bile salts, and c)
lysozyme; 2) physiological properties such as a) auto-aggregation, b) co-aggregation,
c) hydrophobicity, d) adhesion to HT-29 cells, and e) cholesterol reduction; 3)
production of desirable substances such as a) bile salt hydrolase, b) antimicrobials, and
c) EPS; 4) bioactivities such as a) immunomodulation and sensitivity to antibiotics. It
was expected to discover new probiotic strains in the end of the study.

3

Chapter 2: Literature Review
Probiotics are defined as living microorganisms that are found naturally in the
body that provide beneficial health effects when consumed in adequate amount (Floch,
2010). During illness, harmful microorganism level increase in the body affecting the
balance of the microorganisms in the body. However, probiotics help in eliminating
excess harmful microorganisms, and this will eventually help in restoring equilibrium in
the body (Floch, 2010). Moreover, probiotics are found in different parts of the body but
mainly in the gut, especially in the large intestine, due to their favorable environment
(Floch, 2010). From the definition, it is concluded that the great number of
microorganism species are classified as probiotics, whereas LAB was widely used in
food and nutritional fields. Generally, LABs are a group of anaerobic microorganisms
which produce lactic acid as a by-product of sugar fermentation (Teuber, 2001).
Moreover, LABS are Gram-positive, catalase-negative, non-spore-forming, can tolerate
acidic environments, and are fastidious as it requires sufficient levels of carbohydrates
(specifically monosaccharide and disaccharide), protein by-products, vitamin, low
oxygen tension in the process of fermentation (Teuber, 2001). Based on the
characteristic of LAB, probiotics belong to the lactic acid bacteria group, which belongs
to different genera, including Bifidobacterium, Enterococcus, Lactobacillus,
Lactococcus, Leuconostoc, Pediococcus, and Streptococcus (Teuber, 2001). However,
studies have shown that the impacts of probiotics are considered strain-specific, meaning
that each strain can be screened individually to prove certain health effects (Kekkonen et
al., 2008). In terms of probiotics' beneficial capabilities, studies have proven that LAB
plays a significant role in changing the intestinal environment by blocking pathogenic
bacteria in the gastrointestinal system, which will reduce pathogen adhesion activity
(Zommiti et al., 2020). In addition, probiotics helped in reducing mucosal inflammation
(Heller & Duchmann, 2003), lactose intolerance, flatulence, and bowel symptoms of
infants' food (O'Mahony et al., 2005). Based on countless studies, it has been shown that
the significant number of species were classified as probiotics as they belong to
Lactobacillus, Enterococcus, and Bifidobacteria (Ankaiah et al., 2021). According to
some studies, newly discovered probiotics are expected to offer huge health benefits in
terms of human health and food manufacturing. Indeed, a study was conducted on
4

fermented dates in Saudi Arabia that isolated L. Paraplantarum D-3, however Araus and
Al-Dhabi succeeded in proving that fermented dates are considered a vulnerable source
of novel probiotics with antifungal and antioxidant functional properties (2017).
For this reason, most researchers are motivated to discover new novel probiotics
or fermented food products due to the huge health benefits behind it. Moreover, a study
was conducted on wheat bran sourdough, whereas 13 LABs were isolated and
categorized as: 7 were identified as Lactobacillus, 4 Leuconostoc spp., and 2
Pediococcus spp (Manini et al., 2016). However, the authors found out that wheat bran is
considered a rich source of new LAB with its favorable characteristic (Manini et al.,
2016). Regarding the isolates, 9 of them can be utilized in the food industry due to their
EPS production and antifungal activity (Manini et al., 2016). This study aimed to
isolate LAB from fruits and vegetables, describe, and discover new probiotics with
different properties, including 1) gastrointestinal tolerance by a) in-vitro digestion, b)
bile salts, and c) lysozyme; 2) physiological properties such as a) auto-aggregation, b)
co-aggregation, c) hydrophobicity, d) adhesion to HT-29 cells, and e) cholesterol
reduction; 3) production of desirable substances such as a) bile salt hydrolase, b)
antimicrobials, and c) EPS; 4) bioactivities such as a) immunomodulation and sensitivity
to antibiotics.
2.1 Probiotic Definition
Before defining probiotics, probiotics were first named as a synonymy word for
“antibiotic,” afterward it has been discovered that the word probiotics is divided into two
parts where ‘pro’ belongs to a Latin word and ‘bios’ to a Greek word which stands for
“for life,” which is the opposite of ‘antibiotics’ that stands for ‘against life’ (HamiltonMiller, 2004; Schepper et al., 2017). Kollath, which is a German scientist, was the first
one who discovered probiotics that were used for malnourished patients to enhance and
restore their health status through various organic and inorganic supplements (Schepper
et al., 2017). In the next year, the definition of probiotics was modified into substances
that are formed by other microorganisms to enhance the growth of other microorganisms
(Azizpour et al., 2009). Later on, in the 1970s, the definition of probiotics was updated
into compounds that provide the host resistance against infection without affecting the
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growth of microorganisms in vitro (O’Sullivan et al., 1992; Azizpouret et al., 2009).
From 1980 to 1990, there were various changes in the definition of probiotics, in 1990 a
scientist called Parker defined probiotics as organisms or substances found in food
supplements that provide microbial balance in the intestine (O’Sullivan et al., 1992;
Gogineni et al., 2013). However, Parker’s definition was not supported as he included
the word ‘substances’ in his definition, which includes other chemical substances such as
antibiotics that differs from probiotics (O’Sullivan et al., 1992; Salminen et al., 1999). At
last, most researchers agreed with Fuller's definition, which declared that probiotic
benefits the host by providing intestinal microbial equilibrium (McFarland, 2015).
Nevertheless, his definition works more on animals than humans (Azizpour et al., 2009).
The final definition was proposed by FAO/WHO ((Food and Agricultural
Organization/World Health Organization) to be as ‘live microorganisms that offer a
health impact on the host when consumed in adequate amount” (FAO/WHO, 2002).
2.2 The History of Probiotics
Probiotic usage is not new in the process of discovering new microorganisms, as
it was found over 10,000 years ago (Ozen & Dinleyici, 2015). Indeed, Egyptian
hieroglyphs identified some sort of fermented milk, such as Labna Rayeb and Laban
Kha,d in the early 7000 BCE (Gogineni et al., 2013; Ozen & Dinleyici, 2015). In
addition, Tibetan nomads used to apply a traditional method to Yak milk to preserve it
for longer periods (Azizpour et al., 2009). In the 1800s, Branett (2000) discovered the
health effect of consuming the number of fermented milk products, but unfortunately, it
remained unknown; although it was approved by Louis Pasteur that bacteria and yeast
are considered the byproducts of the fermentation process, it still did not relate these
byproducts to any health benefits.
A Russian Zoologist Elie Metchnikoff worked with Pasteur in 1905 and
concluded that the reason behind the long life in most Bulgarian farmers' population is
Lactobacilli that ferment the yogurt they used to consume (McFarland, 2015). In 1922
health improvement was seen in patients with diarrhea, chronic constipation, and eczema
as a result of Lactobacillus acidophilus, which was included in all three cases' treatment
plans (Rettger et al., 1938). In addition, Lactobacillus acidophilus showed a health
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enchantment in volunteers with mental disease and constipation (Kopeloff et al., 1932).
The belief that yogurt is the best and the main type of probiotic led to a debate about
using lactic acid bacteria as yogurt starters (Streptococcus thermophiles and Lb.
bulgaricus), but these starters failed to colonize human intestine (Kopeloff et al., 1932).
Therefore, Lactobacillus acidophilus was injected into milk which succeeded in
colonizing the human colon without increasing the acid level (Ozen & Dinleyici, 2015).
Due to this colonization, researchers termed ‘this complicated interaction of normal
flora, and its ability to withstand the attack of pathogenic bacteria’ as colonization
resistance (McFarland, 2015).
In terms of probiotic description, in 1965, two researchers presented a new form
to the previous description. Indeed, they were the first to categorize compounds that are
secreted by another microorganism that promote the growth of another microorganism
considered as probiotics (Lilly & Stillwell, 1965). Nevertheless, the widespread myth
that yogurt is the superior form of probiotics was rejected by the global guidelines on
probiotics and postbiotics of the World Gastroenterology Organization in 2013, as
probiotics efficiency depends on specific doses and strain (McFarland, 2015). A year
later, according to the International Scientific Association for probiotics and prebiotics,
probiotics are classified into three categories: 1) group that are considered safe and do
not require efficient evidence, 2) probiotics that offer health benefits and are mainly used
in food supplements, 3) probiotic drug which undergoes clinical strain procedures as
well as risk and benefits evaluation to confirm that the drug is safe to use according to
the regulatory standards for drug production (Hill et al., 2014).
2.3 Probiotic Classification and Taxonomy
The various number of microorganisms are classified as probiotics based on their
favorable characteristics (Khalighi et al., 2016). In terms of naming, bacteria are usually
named according to their description, the place of classification, the name of the
scientists classified, or an organization (Schepper et al., 2017). However, based on the
countless studies conducted, it has been found that bacteria that are classified as LAB
demonstrated great interest in the field of food and nutrition. According to LABs'
characteristics, they are anaerobic, Gram-positive, catalase-negative, non-spore-forming,
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acid-tolerant, and fastidious (Schepper et al., 2017). Moreover, in the process of
fermentation, L ABs form lactic acid as byproducts when fermenting sugar (Felis &
Dellaglio, 2009). Orlajensen divided LAB genera into 7 groups based on their
morphologic and phenotypic characteristics, which include1) Mycobacterium, 2)
Betabacterium, 3) Thermocautery, 4) Streptococcus, 5) Tetracoccus, 6)
Streptobacterium, 7) Betacoccus (Holzapfel et al., 2001; Tindall, 2008). Having general
knowledge about the bacteria’s classification and taxonomy is confedered significant as
it determines the strain’s source, physiology, and habitat that will help in selecting new
strains that might either be used in food application or be utilized as probiotics
(Holzapfel et al., 2001). Probiotics belong to lactic acid bacteria that are composed of
Lactobacillus, Streptococcus, Bifidobacteria, or Enterococcus (Remacle & Reusens,
2004). As mentioned previously, these genera produce lactic acid as byproducts in the
process of fermentation after fermenting glucose (Mayo et al., 2008).
Firstly, Lactobacillus belongs Lactobacillaceae family, which is characterized as
rod-shaped, phylum Firmicutes (Pfeiler & Klaenhammer, 2013). Lactobacillus bacteria
plays a significate role in the field of the food industry, specifically in the production of
fermented products such as yogurt, cheese, and fermented sausages (Felis & Dellaglio,
2007). Indeed, Lactobacillus delbrueckii subsp. bulgaricus, which belongs to the
Lactobacillus genera, is considered the superior vehicle in yogurt and cheese production
(Felis & Dellaglio, 2007).
Secondly, Bifdobacteira is a well-known genus that is classified as a probiotic
microorganism that is characterized by a branched shape (Pfeiler & Klaenhammer,
2013). This genus is considered one of the members of the phylum Actinobacteria and
Bifidobateriacae family (Pfeiler & Klaenhammer, 2013). It has been proven that
Bifidobacteria members, such as B. longum and B. animalis, demonstrated healthpromoting benefits both in-vivo and in-vitro (Ventura et al., 2004).
Thirdly, Enterococcus, which belongs to the family Enterococcaceae, that exists
in groups, in short chains, in pairs, or in single and is classified as cocci-shape
(Holzapfel & Wood, 2014). Enterococcus species favor acidic environments; indeed,
their main habitat is in the gastrointestinal tract (GI) (Zhong et al., 2017). Like
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Lactobacillus, Enterococcus also plays a great role in the field of food production,
mainly in dairy products (Foulquié Moreno et al., 2006). In addition, Enterococcus
produces bacteriocins to suppress the growth of foodborne pathogens (Giraffa, 2003).
According to some studies conducted, which stated that Enterococcus species are
correlated with some types of infectious diseases (Gaet et al., 2014).
And finally, Streptococcus are gram-positive bacteria that belong to the phylum
Firmicutes, and the family Streptococcaceae exists in chains and pairs (Gao et al., 2014).
Moreover, Streptococci are considered homofermentative since they do not form CO2 as
byproducts in the process of glucose fermentation (Gao et al., 2014). In addition, their
favorable growth temperature is 37℃ (Holzapfel & Wood, 2014). In terms of food
production, the specie Streptococcus thermophilus is included in the production of
yogurt, cheese and other types of cheese as it is used as a starter culture in the process of
production.
2.4 Health Benefits of Probiotic
Several studies have been conducted to determine the health-promoting benefits
of probiotics, which stated that their impacts are considered strain-specific (Kekkonen et
al., 2008). For this reason, screening strain efficacy is required to determine each health
effect and to determine the capability of some strains to provide microbiota equilibrium
within the GI of the host (Hertzleret et al., 1997). Furthermore, it has been reported that
probiotics play a significant role in reducing mucosal inflammations (McCarthyet et al.,
2003). Besides, probiotics minimize the effects of lactose intolerance, abnormal colonic
fermentation, flatulence, and symptoms of infant food (O'Mahony et al., 2005). In
addition, probiotics helped in inhibiting the growth of some disease-induced pathogens
by blocking the attachment of pathogens in the digestive epithelium (Ariful et al., 2010).
Moreover, probiotics reduce the risk of diarrhea through their antimicrobial activity that
kills or inhibits the growth of the pathogens behind it (Ariful et al., 2010).
2.4.1 Inflammatory Bowel Disease (IBD)
Inflammatory bowel disease is a chronic disease that causes inflammation in the
tissues of the digestive tract (Baumgart & Carding, 2007). There are two main types,
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which are Crohn’s disease (CD) and Ulcerative colitis (UC) (Baumgart & Carding,
2007). Crohn’s disease is caused by inflammation in the lining of the digestive tract
(Baumgart & Carding, 2007). While Ulcerative colitis results in ulcers in the lining of
the colon and rectum (Baumgart & Carding, 2007). Both types have the same symptoms,
which include diarrhea, rectal bleeding, abdominal pain, and fatigue (Baumgart &
Carding, 2007). However, studies showed that probiotics could reduce the effect of both
types of IBD (Mowat & Bloom, 2013). According to some studies, it has been noticed
that the composition of fecal microbiota in IBD patients differs from the composition of
healthy controls (Huttenhower & Xavier, 2014). Under experimental conditions, it has
been seen that Lactobacillus strains succeeded in reducing symptoms of inflammation
(Liang et al., 2014).
According to the screening of Lactobacillus GG strains and after using it in
patients with IBS, including both types of UC and CD, it has been found that those
strains gave effect as mesalazine medication, which is an anti-inflammatory drug (Zocco
et al., 2006). This study was conducted on 187 patients that were randomized to three
open-label arms, including 1) Lactobacillus rhamnosus GG (Lb. rhamnosus GG) added
with mesalazine, 2) Lb. rhamnosus GG strains only, 3) and mesalazine only (Zocco et
al., 2006). In conclusion, the two trials showed that Lactobacillus displayed the same
effect as the medication drug (Zocco et al., 2006). Another study was performed on 21
UC patients that were given Bifidobacterium fermented milk supplements; however,
those patients exhibited fewer relapses throughout the whole duration of the study (12
months) (Ishikawa et al., 2003). To sum up, probiotic treatment succeeded in giving the
same effect as most drugs used to treat UC.
2.4.2 Irritable Bowel Syndrome (IBS)
Irritable bowel syndrome (IBS) is a common condition that disturbs the digestive
system due to the fermentations that occur in the colon, which affects the gas volume in
the body (Defrees & Bailey, 2017). Changes in the gas volume in the body might result
in some symptoms, such as flatulence, abdominal pain, and bloating (Defrees & Bailey,
2017). Some strains of probiotics can be used in IBS patients to minimize gas
accumulation (Charalampopoulos & Eds, 2009). Indeed, some studies have reported that
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including Lactobacillus and Bifidobacterium in the treatment plan of IBS patients
resulted in strengthening immune response, enhancing digestive permeability, and
changing colon fermentation to avoid gas accumulation in the body (Sartor, 2004). IBS
symptoms can be reduced by using probiotic supplements, which work in chaning the
path of the gut-brain axis (Cryan & O'Mahony, 2011). Probiotics that showed great
effects on reducing IBS symptoms include Lb. paracasei, B. infantis, B. breve, and B.
longum (Cremon et al., 2017; Giannetti et al., 2017).
2.4.3 Acute Diarrhea
Acute Diarrhea can be due to a wide variety of reasons, either bacterial, viral, or
parasitic (Drancourt, 2017). However, rotavirus is the main cause of acute diarrhea
among children (Drancourt, 2017). During infection, proteins get destroyed due to the
elevation of the permeability in gut cells (Shah, 2007). The duration of rotavirus diarrhea
can be shortened by using some strains of probiotics such as B. animalis Bb-12 and Lb.
acidophilus (Park et al., 2017a). In the case of antibiotic-associated diarrhea, a strain
with an inhibitory effect against entero-pathogens can be used to reduce or prevent
symptoms (Shah, 2007). In point of fact, yogurt mixed with B. longum showed a great
effect in reducing the diarrheic effect of the antibiotic erythromycin (Shah, 2007).
2.4.4 Allergic Diseases
The causes leading to allergic diseases are still unclear as the method that explains
the effect of the bacteria on the growth and intensity of allergic diseases requires more
investigation. In general, modification in the balance of Th1/Th2 cytokines might trigger
the activation of Th2 cytokines, which will release interleukin-4(IL-4), IL-,5, and IL13
and will produce IgE (Michail, 2009). However, in this case, probiotics might lead to
enhancing the immune tolerance in the gut in the first year of life. Indeed, a study was
conducted on infants and stated that infants who were supplemented with probiotics had
less ratio of eczema compared to the control group (Zuccotti et al., 2015).
2.4.5 Colon Cancer
Several studies were performed both in-vivo and in-vitro and demonstrated the
impact of probiotics, including Bifidobacteria and Lactobacillus strains, or a mixture of
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probiotics and probiotics, on the growth of transplantation metastasis and chemicallyinduced tumor such as colon cancer (Charalampopoulos & Eds, 2009).
However, their accurate prevention method for the growth of colon cancer is still
unclear, but several studies were investigated to clear it out, which include: 1) changes in
the metabolic actions of intestinal microflora, 2) physiological or chemical modifications
within the colon, 3) killing and destroying carcinogens in the body, 4) qualitative and
quantitative change in the intestinal microflora to prevent the production of promoters
and expected carcinogens, 5) production of anti-mutagenic or anti-tumorigenic
substances, 6) enhancing immune response of the host, 7) applying some physiology
changes on the host (Rafter, 2004). There are specific strains of probiotics that are well
known to perform anticancer activities against Cao-2 cells; those probiotics include
Lactobacillus pentosus B281 and Lb. plantarum B282 (Saxami et al., 2016).
2.5 Health Benefits of Food Products Fermented by Probiotics
Fermented food products are described as the end products of bacterial activity on
a specific product that resulted in changes in their chemical, physical, and biological
properties (Pihlanto & Korhonen, 2015). Fermented food products are composed of
microbial metabolites, including lactic acid, acetic acid, alcohol, CO2, propionic acid,
exopolysaccharides, and bioactive peptides that are liberated in the process of
fermentation (Gan et al., 2017). The production of those bioactive peptides plays a
significant role in performing various bioactivities such as antihypertension, cholesterolreduction, antioxidant, and anticancer activities, and each will be explained more
separately.
2.5.1 Antihypertension Property
Peptides that exhibit antihypertensive activities are the most tested peptide in the
process of food fermentation by probiotic bacteria (Fujita et al., 2017). Those peptides
can result in lowering blood pressure by preventing the conversion of angiotensin I to
angiotensin II (Zhang et al., 2017). For this reason,angiotensin-converting enzyme
(ACE) inhibitory peptides acquired from food proteins, efficacy in lowering blood
pressure is much higher than hypertension medication (Haque & Chand, 2008).
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Moreover, one of the studies showed that soybean meal that is fermented by Bacillus
Subtilis exhibited antihypertensive activity (Wang et al., 2017).
2.5.2 Cholesterol-Reduction Property
According to some documentation, bioactive peptides with hypocholesterolemic
activities are liberated as a result of the proteolysis of casein, β-lactoglobulin, soy
protein, and fish protein (Kudaet et al., 2016). Ataie-Jafari and his collogues reported
that serum total cholesterol level was reduced due to the consumption of fermented
yogurt by Lb. acidophilus and B. lactis (2009). Another study stated that consuming
Kimichi, which is Korean traditional food, is fermented by different strains of Lb.
plantarum showed a great role in removing cholesterol (Park et al., 2017b).
2.5.3 Antioxidant Property
Body cells can be destroyed with the presence of free radicals, as these free
radicals are composed of oxygen molecules with an uneven number of electrons which
can easily bind with molecules and cause destruction. This process is known as oxidation
(Lobo et al., 2010). Moreover, this cellular destruction due to free radicals might lead to
different diseases such as diabetes, cancer, arthritis, and atherosclerosis (D’Souzaet et al.,
2002). Pessione and Cirrincione (2016) stated that the consumption of fermented with
probiotics could reduce the effect of these free radicals. There are several peptides that
provide antioxidant activities in various fermented food. However, their efficacy can be
tested by determining its inhibiting lipid peroxidation and scavenging free radicals
(Tamanet et al., 2016). In terms of pedetids composition, peptides with antioxidant
activities are enriched in aromatic and/or hydrophobic amino acids (Sarmadi & Ismail,
2010). Nevertheless, antioxidant activity has been described in the vegetable-fruit
beverage that was fermented by L. plantarum as results indicated significant antioxidant
activity that played a role in forming high-quality fermented products (Yang et
al., 2018).
2.5.4 Anticancer Properties
Several studies have described the anticancer activity in peptides of fermented
food products by probiotic bacteria. In point of view, one of the studies observed their
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activity on fermented goat milk by Lb. plantarum and Lb. paracasei; however, results
showed that with higher concertation of goat milk hydrolysate, there was a reduction in
Hela cells level, which are cervical cancer cells (Nandhini & Palaniswamy, 2013). In
addition, it has been documented that fermented camel milk injected with Lb. reuteri and
Lb. Plantarum displayed anticancer activity against colon cancer cells (Caco-2), breast
cancer cells (MCF-7), and Hela cells (Ayyash et al., 2018b).
2.6 Importance of Isolating New Probiotics
LABs are considered the most abundant microorganisms that are usually isolated
in the field of probiotics. Indeed, various studies discovered several numbers of species
that belong to a group of probiotic bacteria, including Lactobacillus, Enterococcus, and
Bifidobacteria (Ankaiah et al., 2017; Liuet et al., 2017; Quattrinet et al., 2018).
Identifying new probiotic bacteria will expand their beneficial effect on both human
health and the food industry.
As mentioned previously, new probiotics were isolated from fermented date in
Saudi Arabia, which is Lb. paraplantarum D-3 has also been found that dates are
considered a rich source of new probiotic strains due to their antioxidant and antifungal
activities (Arasu & Al-Dhabi, 2017).
In addition, 21 new strains of LAB were isolated from ham, such as Lb.
paraplantarum-GS54, Lb. plantarum GS16, which were classified as bacteriocin-like
substance producers (Anacarso et al., 2017).
2.7 Characterization of Probiotics
For microorganisms to be classified as probiotics, they should show certain
probiotics favorable characteristics. According to the guidelines of FAO/WHO (2002),
the in-vitro test should be performed on each probiotic strain to test their efficiency. For
this reason, in-vitro teste has been applied to various expected probiotic strains for the
initial selection (Morelli, 2000).
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2.7.1 Tolerances to the Gastrointestinal Tract (GI) Conditions
The guidelines stated by FAO/WHO (2002) emphasize the importance for
probiotics to withstand and survive GI conditions to ensure their viability within the
GIT, which is their main habitat. There are some conditions that might affect their
survival, such as low pH (2.0) and pepsin activity. Moreover, probiotics should pass by
the stomach within less than 1 to 4 hours (Ruiz-Moyano et al., 2010). Selected probiotic
strains should succeed in passing by the GIT to provide their beneficial health effect on
the host (Shokryazdan et al., 2017). In terms of probiotic survival, there are some
obstacles that might prevent them from surviving within the GIT, like the presence of
trypsin and bile salts. However, probiotics should be able to defeat and withstand these
obstacles.
2.7.2 Probiotics Cell Surface Properties
In order to apply the beneficial effect of probiotics on the host, their population
should be more than 6.0 log CFU/g (Shah, 2000). For probiotics colonization to take
place, probiotics should first attach to the intestinal epithelial cells (Lee & Salminen,
1995). Thus, probiotics attachment to the host’s GIT is considered a significate criterion
to provide its beneficial effects. Auto-aggregation, hydrophobicity, and co-aggregation
act as indicators to evaluate probiotics attachment (Hernández-Alcántara et al., 2018).
2.7.2.1 Auto-Aggregation
One of the indicators for probiotics' ability to attach to the GIT is autoaggregation, which is performed to determine the ability of bacterial strains to aggregate
with each other (Del et al., 2000).
2.7.2.2 Hydrophobicity
Hydrophobicity is usually conducted to identify the ability of probiotics to attach
to hydrocarbons that result in a strong link (Piwat et al., 2015). Since hydrophobicity is
considered a parameter for cellular attachment, it means that probiotic strain with high
hydrophobicity will be more attached to GIT walls (Shokryazdanet et al., 2017). Indeed,
countless numbers of studies stated the correction between hydrophobicity and auto-

15

aggregation test with probiotic attachment to the host’s GIT (Boteset et al., 2008;
Tarebet et al., 2013; Felipet et al., 2017).
2.7.3 Co-aggregation
Co-aggregation is performed to describe the aggregation ability among bacteria of
various species (Piwat et al., 2015). One of the main defensive barriers that prevent
pathogens from attaching to the host’s mucosa is the direct aggregation of probiotics
with pathogens (Vidhyasagar & Jeevaratnam, 2013). Moreover, studies proved that the
presence of gut pathogens enables co-aggregation to enhance probiotics properties as
well as their attachment to gut cells (Peres et al., 2014; Amaral et al., 2017).
2.7.4 Antimicrobial Activity
One of the significant characteristics of probiotics that should be present in
expected bacterial strains is antimicrobial activity. The efficiency of antimicrobial
activity of probiotic strain is usually tested by the production of organic acid, metabolite,
and bacteriocins during probiotic growth. Bacteriocins produced by these bacteria are
significate as they are utilized as food bio-preservatives. In addition, bacteriocins are
heat-stable peptides that defeat pathogenic bacteria via their antimicrobial activity (Nami
et al., 2015). Besides, it has been reported that Enterococcus spp. Isolated from fresh
shrimps exhibited antimicrobial activity against various indicator strains (Ben Braiek et
al., 2017).
2.7.5 Antibiotic Resistance
All selected probiotics should go through a safety assessment before selection
which is performed by testing their resistance against antibiotics. Probiotics’ antibiotic
resistance can be affected by membrane impermeability and cell wall structure (İspirli et
al., 2017). However, one of the main criteria for potential probiotics is to exhibit
sensitivity toward antimicrobial and antibiotic components (Peres et al., 2014). One of
the studies was conducted on Feta cheese which isolated Lactobacillus spp. that showed
sensitivity toward some antibiotics (Plessas et al., 2017).
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2.7.6 Hemolytic Activity
The safety of the potential probiotic strains should be investigated before using it
in food products through hemolytic activity, as the epithelial layers might be broken
down by the strains that shows positive hemolytic activity. Isolates that didn’t exhibit
hemolytic activity are considered as non-virulent strains making them safe since they
don’t cause infections (Tejero-Sariñena et al., 2012). Indeed, one of the studies
conducted on Enterococcus faeclais and Weilissela sp. that was isolated form fish which
showed negative results in the hemolytic activity test (Shahid et al., 2017). However, due
to unavoidable circumstances this test was not performed in this study.
2.7.7 Bile Salt Hydrolysis
Conjugated bile salts are usually hydrolyzed by a specific type of enzyme known
as bile salt hydrolase (BSH), which is formed by potential probiotics. One of the end
products of these conjugated bile salts is micelle with cholesterol, which to enhances the
absorption of cholesterol. Thus, the hydrolysis of conjugated bile salt to deconjugated is
significant as it plays a role in reducing the absorption of cholesterol in the host’s
intestine. This reduction occurs by minimizing cholesterol solubility resulting in elevated
levels of cholesterol excreted with fecal (Shokryazdan et al., 2017). The impact of
deconjugated bile salts was documented in vitro by Lactobacillus isolates from chicken
(Ramasamy et al., 2010).
2.7.8 Cholesterol Removal
Cholesterol removal can be performed through various methods, either via
assimilation, binding to the cell surface, embedding in the cell wall, or co-perception
with deconjugated bile (Kumar et al., 2013; Noh et al., 1997). It has been reported that
LAB with active BSH worked in lowering cholesterol levels by interacting with the
metabolism of the host bile salt (De Smet et al.,1998). Point of view, a study was
performed on Kimchi that isolated Lactobacillus plantarum, which showed significant
removal of cholesterol (Choi & Chang, 2015).
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2.7.9 Heat Tolerances
Potential probiotic strains might get exposed to heat during the processing and
storage phase in food processes (Aakko et al., 2014). Moreover, probiotics that were not
able to tolerate heat showed less progress in most food production phases. Heat might
result in several effects,s such as altered membrane fluidity, which might lead to the
destabilization of several macromolecules such as RNA and ribosomes (Guchte &
Serror, 2002). For this reason, heat tolerance is one of the main criteria that should be
present in potential probiotics to enhance their efficiency during fermented food
production. As an example of good heat-resistant probiotics, Lactobacillus
kefiranofeciens MI, which was isolated from Taiwanese kefir grains, showed great heat
tolerance (Chen & Chiang, 2017).
2.7.10 Lysozyme Tolerances
Lysozyme is an antimicrobial enzyme (EC 3.2.2.17) that is usually formed in
tears, human milk, saliva, neutrophil granules, mucus, and egg white. However, potential
probiotic strains should tolerate the effect of lysozyme. Lysozymes target gram-positive
bacteria more than gram-negative as they might result in the destruction of gram-positive
bacterial cell walls (Rada et al., 2010). In terms of lysozyme tolerance, the dairy product
requires probiotics with a range of lysozyme tolerance between 25-35 mg/L (Guglielm et
al., 2007). Ladakh isolated LAB strains exhibited tolerance toward lysozyme activates
(Angmo et al., 2016).
2.7.11 Exopolysaccharides (ESP) Production
Exopolysaccharides provide cellular protection against toxic metals,
bacteriophage attacks, and the innate immune factors of the host (Zannini et al., 2016).
Besides, the dairy products industry requires probiotics that are able to produce ESP due
to their improving impact on the rheological properties, texture, and taste of their
products (Caggianiello et al., 2016). It has been found that ESP results in several health
impacts, including 1) cholesterol reduction, 2) exhibiting antihypertensive activity, 3)
amending fecal microbiota, and 4) protecting epithelium cells against intestinal
pathogens (Bengoa et al., 2018). Moreover, a study reported that Turkish wheat
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sourdough isolated probiotics strains that were able to produce ESP, such as Lb.
sanfranciscensis ED5, Lb. rossiae ED1, Lb. brevis ED25 and Lb. plantrarum ED10
(Dertli et al., 2016).
2.8 Isolating Novel Probiotics from Traditional Foods
Most researchers are motivated to discover new probiotic strains from fermented
food products due to the countless beneficial health impacts they offer. Manini and his
colleagues discovered 13 LABs isolated from wheat bran sourdough, which were
composed of 7 isolates of the Lactobacillus group, 4 Leuconostoc spp., and 2
Pediococcus spp (2016). Besides, all authors agreed that wheat bran sourdough is
considered a wealthy source of new LAB with all favorable probiotic characteristics
(Manini et al., 2016). In addition, 9 of the total isolated exhibited antifungal activity and
were able to produce ESP, which will enable them to work efficiently in food industries
(Manini et al., 2016). Regarding the limitations of the study, which was in the bile salt
tolerance test, it was tested against oxgall only, and the antimicrobial activity assessment
was performed against Listeria spp., only.
Another study was conducted on fermented cereals that isolated two strains of Lb.
plantarum ULAG11 and ULAG24 in which both showed great resistance against acids
and salt, while ULAG24 produced bacteriocins that inhibited the growth of pathogens
(Oguntoyinbo & Narbad, 2015). In addition, ULAG24 was able to attach the HT29 cell
line and BALB/C gut. However, the limitation of this study was in the acid tolerance
assessment as pepsin was not added to the potential strains which affected LAB survival.
New probiotics were identified by Abbasiliasi (2017) and his colleagues, which
isolated Pediococcus acidilactici kp10 from dried crude. In terms of characteristics,
Pediococcus acidilactici kp10 displayed tolerance against phenol. Their antimicrobial
activity played a role in defeating food-borne pathogens and produced peptidase and
esterase-lipase (Abbasiliasi et al., 2017). Due to these characteristics, this probiotic is
expected to work efficiently in the food industry. In terms of limitation, this study did
not determine tolerance toward gastric and bile conditions.
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2.9 Vegetables Production in UAE
The production and agriculture of most vegetables and crops are one of the main
challenges faced in the UAE due to various land, water, and management challenges
(Fathelrahman et al., 2017). However, vegetable production can occur under greenhouse
conditions which enable crops to be produced in the offseason (Fathelrahman et al.,
2017). According to the Ministry of Water and Environment (2022), in 2012, the
vegetable production rate in the UAE reached 364 million AED, which is equivalent to
$100 million USD. Most of the vegetable agriculture was carried out in Abu Dhabi.
Indeed, statistics held by the UAE Bureau of Statistics displayed that 40% of the total
agriculture of vegetables took place in Abu Dhabi. Farming is considered one of the
emerging practices in the UAE as a large group of the population owns noncommercial
small farms to raise their own fresh crops. Point of view in 2012, the International Center
for Biosaline Agriculture ICBA reported that 70% of the total farms in the UAE were
created to provide fresh vegetable and meat animals for home use purposes (Degefa et
al., 2021).
2.10 Thesis Objective
As mentioned earlier, raising fresh vegetables is one of the common practices
spread in the UAE, in which these vegetable products can be used to isolate potential
probiotics that can be later used in food industries. However, this article was performed
to improve the health benefits of vegetable products and to identify new LAB with all
favorable characteristics. In terms of the thesis of objectives were to isolate LAB from
fresh fruits and vegetables and new potential probiotics characteristics, including:
1) tolerance to the gastrointestinal conditions by a) in-vitro digestion, b) bile salts, and c)
lysozyme;
2) physiological properties such as a) auto-aggregation, b) co-aggregation,
c) hydrophobicity, d) adhesion to HT-29 cells, and e) cholesterol reduction;
3) production of desirable substances such as a) bile salt hydrolase, b) antimicrobials,
and c) EPS production;
4) Immunomodulatory activities such as a) Immunomodulation and sensitivity to
antibiotics.
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Chapter 3: Methodology
3.1 Sample Collection
Samples (140) of fresh vegetables (various types, namely tomato, cucumber,
strawberry, peach, lettuce, parsley, cabbage) were collected from local markets (Sharjah,
UAE) and transported in an icebox to the food microbiology lab of the University of
Sharjah, Sharjah, UAE, where the isolation on MRS agar was carried out.
Characterization of the LAB isolates as potential probiotics was carried out in the food
microbiology lab of United Arab Emirates University (UAEU). Unless otherwise
mentioned, the isolation and characterization were completed using Sigma-Aldrich
chemicals (St. Louis, MO, USA).
3.2 Isolation of Lactic Acid Bacteria
The pour-plate technique was performed using MRS agar (de Man, Rogosa and
Sharpe; LAB-M, Heywood, UK) by mixing the sample with 99 mL MRS broth that is
supplemented with 2% NaCl which was then blended for 2min, the mixture was then
incubated for 24h at 37°C. After incubation, spread plate method on MRS agar was
performed to the isolates from the incubated mixture, then the plates were incubated at
37°C for 24 h anaerobically in a CO2 incubator (Binder C 170, Germany) for MRS. The
Gram-positive and catalase-negative isolates were sub-cultured in MRS broth, and then
the working stocks were prepared using 50 mL:50 mL glycerol: water. The stocks were
stored at -80°C. The overnight activation at 37°C was carried out to investigate the
potential probiotic characteristics of the isolates.
3.3 Tolerance to Stimulated Digestion Condition using INFOGEST2.0
The tolerance of the potential probiotic strains against In-vitro digestion
conditions were performed according to the method of INFOGEST2.0 as described by
Brodkorb and his colleges (2019). However, the 46 isolates were activated in MRS broth
then was kept for 18hrs at 37℃. Later, overnight grown isolates were centrifuged at
5000x g at 4°C for about 10 min, and then the pellets were re-suspended in 0.1 mM
sodium phosphate buffer (pH 7.0). After each digestion phase, 1 ml sample of the digest
was aseptically taken, and serial dilution was made before being spread out on MRS and
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M17 agar. Isolates to be classified as probiotics should survive several stresses while in
GIT transit, including the low pH of the stomach, bile salts, and digestive enzymes
(Ayyash et al., 2021). Thus, at this stage IN-120, isolates with the higher survival rates
were selected for further investigations. After incubation at 37°C for 48 h, the plates
were counted using a colony counter (Interscience San 1200; NY, USA). As a result of
IN-120, 17 out of the 46 isolates had a significant reduction compared to their average in
G0, which were excluded from further investigations.
3.4 Bile Salts Tolerance
As described by Li and Huo (2020), bile salt tolerance was carried out by
adding cholic acid (0.30%), taurocholic acid (1.0%), and ox gall (1.0%) separately to the
overnight activated isolates. After addition, plates were then incubated at 37℃ in
temperature-controlled EpochTM microplate spectrophotometer (Epoch-2, BioTek; VT,
USA). The absorbance was then measured at 620 nm at three different incubation times
0, 3, and 6 hrs. before each absorbance time, microplate instrument was used to shake
each isolate for 5 sec.
3.5 Identification of the Probiotics
The 16S rDNA of the selected isolates was amplified according to AlKalbani et
al. (2019). using PCR primers 27F (5’-AGAGTTTGATCCTGGCTCAG-3’) and 1492R
(5’- TACGGYTACCTTGTTACGACTT-3’), and 16S rDNA sequence of the PCR
product was done by Macrogen Sequencing Facilities (Macrogen, Seoul, Korea). The
BLAST algorithm in the NCBI database was used to align the sequences and retrieve the
accession number for each isolate from the GenBank. An online tool developed
by Lemonie et al. (2019) was used to determine the most closely related bacterial species
to the isolates by using MEGA software 7.0, and to create the dendrogram.
3.6 Safety Assessment of Selected LAB Isolated
3.6.1 Antibiotic Susceptibility Test
Antibiotic resistance test was performed according to Shivangi et al. (2018) with
slight modifications as MRS and M17 agar plates were used for the respective isolates.
The susceptibility of the isolates was tested against penicillin (PEN, 10 mg), clindamycin
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(CLI, 2 mg), vancomycin (VAN, 30 mg), and erythromycin (ERY, 15 mg). 4 antibiotic
discs were disturbed on MRS agar spread by selected LAB isolates. However, caliber
was used to measure the diameter of the inhibition zone (mm).
3.7 Bile Salt Hydrolase (BSH) Activity
BSH activity can be observed by measuring the number of amino acids released
from conjugated bile salts (6mM)) by LAB isolates as reported by Ayyash et al. (2018a).
MRS broth was used to culture bacterial cells for 20 h at 37℃, which is then centrifuged
at 4000x g for 15 min at 4°C. after washing the pellet with sterilized distilled water, they
were suspended in 5mL of 0.1M PBS (pH6.0). Cell suspension was sonicated four time
of 1 min interval by sonicater bath 2510 (Branson, Danbury, CT, USA), which is then
cooled for 2 min in ice bath between each interval. Following by, these cell suspension is
then centrifuges at 1000 x g for 5 min at 4°C. however, 100 μL of cell suspension was
added with 1. mL of 0.1M PBS (pH 6.0) and 100 μL of tested bile salts that is a mix of
6mM sodium glycocholate, 6mM sodium taurocholate or 6 mM conjugated bile salt
mixture (sodium glycochenodeoxycholic, taurocholic, taurochenodeoxycholic,
and taurodeoxycholic acids). The mixture was then incubated for 30 min in the water
bath at 37℃. Trichloroacetic acid (15%w/v) was added to inhibit the enzymatic reaction.
After this addition, the mixture was centrifuged for 15 min at 4°C, and then 500 μL of
the supernatant was mixed with 1 mL of distilled water, 1mL of ninhydrin reagent (500
μL of % ninhydrin in 0.5 M citrate buffer pH 5.5), 2 mL of 30% glycerol and 0.2 mL of
0.5M citrate buffer pH 5.5. this whole mixture was then vortexed for 30 s, then boiled at
100°C for 15 min, which was kept later to cool at room temperature. The mixture’s
absorbance was measure at 570 nm using a Epoch-2 Microplate Spectrophotometer
(BioTek, CA, USA).
3.8 Cholesterol Removal
The ability of the isolates to remove cholesterol was tested based on the method
of Shivangi et al. in order to produce cholesterol stock solution, 30mg of
polyoxyethancyl-cholesterol sebacate (water-soluble cholesterol) was dissolved in 10ml
of distilled water. Furthermore, final cholesterol concentration 100 μL/mL was formed
by mixing 100 μL of cholesterol stock with 9.9 mL of MRS broth that is added with
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0.3% oxgall. After producing the final cholesterol concentration 100 μL, centrifugation
at 4000 x g for 14 min at 4°C was performed to remove bacterial cells. Afterwards, 1 mL
of the supernatant was mixed and vortexed for 1 min with 2 mL of 96% ethanol and 1
mL of KOH (33%w/v). The mixture was then incubated in a water bath (ESB-18; WisdWiteg Labortechnik) for 15 min at 37℃ and was then kept to cool down at room
temperature. After this step, 2mL of distilled water and 3 mL of hexane was added to the
mixture and vortexed for 1 min. However, the mixture was kept a side for a while till the
two phases separate. After the two layers form, 1 milliliter of the upper hexane layer was
placed in dried and sterile tubes that was then evaporated under nitrogen gas. The other
dried tubes were used to add 2 milliliters of o-phthalaldehyde (OPA) reagent, which is
50 mg of OPA in 100 mL glacial acetic acid, that is then mixed and vortexed for 1 min
with 0.5 ml of concentrated sulphuric acid. The mixture is then kept for 10 min at room
temperature. The absorbance was measured at 550 nm using Epoch-2 Microplate
Spectrophotometer.
3.9 Auto-Aggregation
Auto-aggregation of the activated cultures was performed according to the
method described by Gao et al. (2021). The 17 selected isolates were cultured 16-8hrs at
37℃ in MRS broth, which is then centrifuged at 5000 x g for 5min at 5℃. Followed by
this step, the pellets were washed by 0.1 M phosphate buffer solution (PBS) at pH 6.87.0 to achieve (107-108 CFU/mL) and absorbance to 0.25. The absorbance was then
measured at three timings 0, 4, and 24 h at 600 nm. Auto-aggregation was estimated
according to the following equation: 37℃
Auto-aggregation (%) = [1 −

At
A0

] × 100

3.10 Hydrophobicity
Hydrophobicity of the isolates to various hydrocarbons, namely xylene,
hexadecane, and octane was evaluated according to Ayyash et al. (2018a). Firstly,
selected LAB isolates were activated and cultured in MRS broth for 16-16h at 37℃.
afterwards, cells were collected by centrifugation at 5000 x g for 5min at 5℃, which was
then washed by 0.1M phosphate buffer PBS at pH 6.8-7.0. then, the cell suspension was
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mixed with 1mL of the hydrocarbon (xylene, hexadecane, and octane); each was added
separately in dry sterilized culture tube that was then vortexed for 2 min. The mixture
was kept on the side for 1h at 37℃ until the separation phase occurred. After separation,
the lower aqueous phase was placed to the UC cuvette (3 mL) by micropipette. The final
absorbance was measured at 600 nm using a Epoch-2 Microplate Spectrophotometer.
3.11 Adhesion to HT-29 Cells
For determining the adhesion ability, the overnight activated isolates were
centrifuged and washed twice with Dulbecco’s phosphate-buffered saline (DBPS). Then
adhesion percentage was estimated as per Oh et al. (2015) using the following equation
At

Adhesion ability (%) = [ ] × 100
A0

3.12 Co-Aggregation
Co-aggregation was examined according to Ayyash et al. (2018a) using four
pathogenic bacteria, namely Escherichia coli 0157:H7 1934, Staphylococcus
aureus ATCC 25923, Salmonella Typhimurium 02-8423,
and Listeria monocytogenes DSM 20649. Firstly, Bran heart infusion (BHI) broth was
used to activate cell suspensions and each cell suspension of the four pathogens at 37℃.
The absorbance was then measured at 0h (A0) at 600 nm, and then without mixing the
mixture was incubated for 4h at 37℃. After incubation, the absorbance was recorded at
2h and 4h (At). The results were expressed as co-aggregation percentages utilizing the
equation below:
Co-aggregation (%) = [1 −

At
A0

] × 100

3.13 Antimicrobial Production
Antimicrobial activity was determined by using a cell-free supernatant as per
Ayyash et al. (2018a). As a start, selected LAB isolates and indicator pathogens were
activated in MRS and BHI broth overnight at 37℃. BHI agar injected with the indicator
pathogen was placed in petri dish and kept for 2h under laminar flow to solidify. In BHI
agar plate, a six 5-mm well was performed in each plate. The cell-free supernatant pH of
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the selected LAB was modified to pH 6.5 ± 0.1 by 1 M NaOH. After this modification,
50 μL was added into the 5-mm well plates and was incubated aerobically for 1 whole
day at 37℃. however, 1mm ≤ of clear inhibition zone (mm) in the well of each plate
indicated positive inhibition.
3.14 Lysozyme activity
Evaluation of LAB isolates tolerance to lysozyme during
90 minutes of incubation at 37℃ was carried out as per Ayyash et al. (2018a). Overnight
activated isolates were centrifuged at 4000 x g for 10 min at 4°C and washed with 0.1M
PBS (pH 6.5) twice. To reach final concentration of 0.1mg/mL, washed pellets were
added to 0.1M PBS (pH 6.5) inoculated with lysozyme. However, survival cells were
then counted on MRS agar that was incubated for two days anaerobically at 37℃.
3.15 Exopolysaccharides (EPS) Production
EPS production indication test (-ve/+ve) was examined as described
by Abushelaib (2017), using milk-ruthenium media. Sucrose, which is composed of
1.0% (w/v), skim milk powder 10% (w/v), agar 1.5% (w/v) and ruthenium red 0.08g/L,
was added to prepare the ruthenium red milk agar. The activated LAB isolates were then
marked on ruthenium red milk agar. However, isolates showing white ropy colony
indicated positive ESP.
3.16 Statistical Analysis
One-way ANOVA was applied to determine if the differences between LAB
isolates had a significant influence on the quantitative parameters (p <0.05). Tukey's test
was used to detect differences between mean values with a p-value of <0.05. To
calculate the mean values and standard deviations, all tests were performed at least three
times. Minitab version 21.0 (Minitab, Ltd., Coventry, UK) was used for all statistical
analyses for non-cell line studies. For the immunomodulatory effects, statistical
significance between control and LAB isolate-stimulated cultures was analyzed by the
unpaired two-tailed Student’s t-test. The statistical analyses were performed using
GraphPad PRISM 8 software (GraphPad Software, San Diego, CA), and differences with
a p-value ≤ 0.05 were considered significant.
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Chapter 4: Results and Discussion
4.1 Tolerance to the Gastrointestinal Conditions
4.1.1 Tolerance to In-Vitro Digestive Condition
One of the main criteria for any microorganism to be classified as probiotics, they
must be able to endure gastrointestinal conditions like low pH, digestive enzymes, and
bile salts (FAO/WHO, 2002). In vitro digestion test INFOGEST 2.0 is used, which
measures microbial survival after each phase of contact with different simulated fluids.
The viability of the microbes is determined by investigating the survival rate of LAB
isolates before and after each phase. The survival rate of LAB isolates after in vitro
digestion using INFOGEST2.0 is shown in Table 1. The salivary phase (G0) of in vitro
digestion begins with the isolates reacting to salivary fluids containing salivary amylase,
followed by the gastric phase (G120). The isolates' survival averaged 8.3 to 9.0 Log10
CFU/mL after the first stage G0 of the INFOGEST, which is similar to the beginning of
the digestion (data not shown); no viability loss was observed in LAB isolates at the end
of the oral phase implying that the LAB isolated survived salivary simulated fluid
containing enzymes. This finding is consistent with previous research, which found the
same behavior (Melchior et al., 2020; Reuben, 2020).
Almost all the bacterial isolates showed a slight decrease in viable numbers
following the gastric phase as the pH in the simulated gastric fluid is maintained at <3,
with varying levels depending on the isolate. Probiotic viability is generally determined
by quantifying its resistance to simulated gastric juice or simulated intestinal fluid
(Grispoldi et al., 2020). Isolates survived after G120 at an average rate of 8.0 to 8.6
Log10 CFU/mL, observing not much significant change in the bacterial number as seen
in G0. The survival of LAB isolates at low pH <3 containing strong gastric enzymes like
pepsin and lipases shows that it can resist the harsh stomach environment. This study
aligns with the previous studies on camel milk isolates (Reuben, 2020; Yasmin et al.,
2020).
After the intestinal phase (IN-120), the bacterial count ranged from 7.3 to 8.5
Log10 CFU/mL in simulated fluid containing bile as well as pancreatin at pH 7. Our
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findings are consistent with those reported (Reuben, 2020; Yasmin et al., 2020; Tarique
et al., 2022) after in vitro digestion. The overall survival rate from the beginning of the
INFOGEST was higher than ~ 90% (Table 1), indicating the resistance to the salivary,
gastric, and intestinal fluid containing different enzymes at different pH.
According to the (FAO/WHO, 2002), probiotics must have the ability to survive
in the low pH, different enzymes, and salts that are seen in our isolates. The mechanism
of resistance to GIT conditions differs depending on the strain and species (Ayyash et
al., 2021). Survival in the harsh environment was used as preliminary criteria to select
the LAB for continuing investigation of Probiotics. Thus, at this IN-120 stage, isolates
with the highest survival rates were selected for further investigations. Out of the 46
isolates only 17 isolates (F1, F5, F8, F13, F15, F18, F21, F23, F25, F26, F28, F31, F37,
F40, F41, F43, F46) with outstanding survival rate were selected for further assessment.
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Table 1: In vitro digestive system tolerance (Log10 CFU/mL) of LBA isolated from
vegetables
Isolates
F1
F2
F3
F4
F5
F6
F7
F8
F9
F10
F11
F12
F13
F14
F15
F16
F17
F18
F19
F20
F21
F22
F23
F24
F25
F26
F27
F28
F29
F30
F31
F32
F33
F34
F35
F36
F37
F38
F39
F40
F41
F42
F43
F44
F45
F46

G0
8.8±0.42
8.6±0.26
8.6±0.28
8.8±0.52
8.9±0.45
8.8±0.37
8.8±0.49
8.9±0.44
8.9±0.54
8.7±0.44
8.8±0.57
8.7±0.53
8.7±0.41
8.7±0.43
8.8±0.38
8.8±0.31
8.8±0.30
8.9±0.46
8.3±0.09
8.4±0.18
8.9±0.49
8.4±0.32
8.6±0.31
8.8±0.46
8.7±0.39
8.8±0.53
8.4±0.68
9.0±0.57
8.8±0.48
8.8±0.51
8.7±0.54
8.9±0.61
8.6±0.57
8.3±0.48
8.6±0.50
8.8±0.43
8.9±0.52
8.7±0.40
8.8±0.54
8.8±0.58
8.9±0.57
8.8±0.51
8.9±0.78
8.8±0.52
9.0±0.52
8.6±0.38

G120
8.3±0.67
8.5±0.76
8.4±0.77
8.5±0.85
8.5±0.85
8.4±0.72
8.4±0.84
8.4±0.79
8.2±0.90
8.4±0.78
8.1±0.87
8.5±0.86
8.4±0.63
8.4±0.77
8.4±0.72
8.4±0.77
8.4±0.69
8.4±0.71
8.1±0.62
8.3±0.68
8.6±0.83
8.3±0.61
8.5±0.88
8.4±0.77
8.3±0.78
8.5±0.87
8.4±0.85
8.5±0.93
8.4±0.90
8.6±1.00
8.4±0.78
8.2±0.63
8.4±0.74
8.0±0.69
8.2±0.59
8.4±0.68
8.4±0.84
8.3±0.66
8.2±0.71
8.5±0.81
8.4±0.72
8.5±0.93
8.5±0.79
8.5±0.87
8.4±0.72
8.4±0.71

In120
8.2±0.59
8.2±0.61
8.1±0.50
8.3±0.70
8.1±0.70
8.2±0.53
8.3±0.73
8.3±0.65
8.3±0.75
8.4±0.73
8.3±0.67
8.4±0.69
8.3±0.74
8.2±0.78
8.5±0.75
8.4±0.68
8.3±0.73
8.4±0.75
7.9±0.58
7.6±0.57
8.4±0.66
8.3±0.64
8.2±0.61
7.9±0.35
8.2±0.59
8.1±0.47
8.1±0.50
8.4±0.81
7.6±0.38
8.1±0.51
8.2±0.50
7.9±0.44
7.7±0.46
8.0±0.40
7.9±0.37
7.7±0.30
8.2±0.50
7.4±0.20
8.1±0.56
8.2±0.52
8.5±0.85
8.1±0.53
8.5±0.74
8.1±0.53
8.4±0.62
8.2±0.49

Values are expressed as the mean ± standard deviation of triplicate. G0 = Salivary phase, G120
= Gastric phase, In120 = Intestinal phase
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4.1.2 Identification by 16S DNA
Using the 16S rRNA, each of the 17 isolates was able to be positively identified,
aligned, and classified into one of five groups of Lactic Acid Bacteria that are
Enterococcus faecium, Enterococcus durans, Enterococcus lactis, Enterococcus faecalis,
and Pediococcus acidilactici and listed with their accession number, as can be seen in
Table 2. To identify Lactic Acid Bacteria at the species level, a molecular phylogeny
analysis and the phylogenic tree was constructed by an online tool
"https://ngphylogeny.fr/." The analysis was based on 16S rRNA sequences, and the
evolutionary distances were calculated using the neighbor-joining method. In Figure 1,
we see an illustration of the phylogenetic tree that includes all 17 isolates. According to
the results of the sequence analysis, 7 out of 17 isolates grouped together with the 16S
rRNA sequences of Enterococcus faecium, 6 out of 17 isolates grouped together with the
sequences of Enterococcus durans, 2 out of 17 isolates grouped together with the
sequences of Pediococcus acidilactici and remaining were Enterococcus lactis and
Enterococcus faecalis each.
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Table 2: Identification of LAB isolates using 16S rDNA gene sequencing and their
accession number from GenBank
Sample
F1
F5
F8
F13
F15
F18
F21
F23
F25
F26
F28
F31
F37
F40
F41
F43
F46

Organism
Enterococcus faecium
Enterococcus durans
Enterococcus lactis
Enterococcus faecium
Enterococcus faecium
Enterococcus faecium
Pediococcus acidilactici
Enterococcus durans
Enterococcus faecium
Enterococcus durans
Pediococcus acidilactici
Enterococcus faecium
Enterococcus faecium
Enterococcus durans
Enterococcus durans
Enterococcus durans
Enterococcus faecalis

Accession No
MW721241
MW721242
MW721243
MW721244
MW721245
MW721246
MW721247
MW721248
MW721249
MW721250
MW721251
MW721252
MW721253
MW721254
MW721255
MW721256
MW721257
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Figure 1: Polygenetic tree based on 16S rRNA sequences. Numbers in parentheses are
accession numbers of identified sequences from GenBank. Filled circles are the
reference strains from NCBI.
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4.1.3 Bile Salts Tolerance
Bile tolerance is one of the most important characteristics of probiotic strains, and
it should possess good resistance toward bile salts to survive in the human
gastrointestinal tract (Abdalla et al., 2021). The selected 17 isolates were exposed to
different bile salts (cholic acid (CA), oxgall (OX), and taurocholic acid (TA)), and their
growth percentages are displayed in Table 2. Therefore, high survival percentages
indicate good bile salts tolerance (Reuben, 2020; Stasiak-Różańska et al., 2021). As
illustrated in Table 3, the survival rates ranged from 22.5 to 53.6%, 32.5 to 51.5%, and
41.8 to 60.9% in MRS supplemented with CA, OX, and TA, respectively, after 3 h of
incubation. After 6 h, the survival rates ranged from 17.8 to 51.1%, 33.6 to 63.9%, and
55.9 to 72.5% for CA, OX, and TA, respectively. As a result, the survival rates generally
increased against OX and TA and decreased against CA. This implies that CA has more
inhibitory effects on the 17 isolates compared with OX and TA. These results are in
accordance with those reported by (Abushelaibi, 2017). In conclusion, most isolates
have reasonable resistance to taurocholic acid and oxgall compared to cholic acid. Bile
salts have a destructive role on the membrane lipids of bacterial cells (Abdalla et al.,
2021). Because of strain or species differences, the bile tolerances of all isolates differed
dramatically. Bile salts are commonly used as detergents, which can harm the lipid
membrane of bacteria. It may cause membrane damage and protein misfolding in the
small intestine, resulting in DNA damage from oxidative stress and low intracellular pH.
The presence of polysaccharides on the outer cell membrane has been suggested as a
possible cause of bile salt resistance (Yerlikaya & Akbulut, 2019; Stasiak-Różańska et
al., 2021; Melchior et al., 2020).
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Table 3: Bile tolerances (%) for 17 selected LAB isolates after 3h and 6h
Isolates
E. faecium MW721241
E. durans MW721242
E. lactis MW721243
E. faecium MW721244
E. faecium MW721245
E. faecium MW721246
P. acidilactici MW721247
E. durans MW721248
E. faecium MW721249
E. durans MW721250
P. acidilactici MW721251
E. faecium MW721252
E. faecium MW721253
E. durans MW721254
E. durans MW721255
E. durans MW721256
E. faecalis MW721257

CA
43.9
29.1
53.7
46.2
45.0
41.4
22.5
26.7
32.3
33.0
26.3
28.0
33.0
36.1
35.3
32.3
37.6

3h
OX
42.7
38.9
40.2
37.4
39.9
40.7
39.7
33.5
40.7
42.5
42.1
35.6
32.5
50.1
40.7
45.1
51.5

TA
56.1
48.7
60.9
59.5
59.0
60.0
49.8
44.9
55.3
41.8
51.2
47.5
45.4
48.3
45.5
56.3
54.8

CA
39.3
27.6
51.1
45.3
41.5
36.4
20.5
23.9
35.4
29.7
17.8
25.2
37.3
34.5
29.3
37.8
44.4

6h
OX
39.9
52.4
39.0
33.6
35.2
38.8
51.1
49.9
55.7
60.6
56.0
52.4
55.8
62.2
42.9
50.4
63.9

TA
58.8
63.0
60.7
60.0
57.0
58.1
63.8
59.6
66.9
56.0
63.5
64.0
62.7
62.2
63.6
72.5
68.6

Values are expressed as the mean ± standard deviation of triplets. CA= cholic acid, OX = oxgall
TA= taurocholic acid
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4.1.4 Lysozyme Tolerance
In the oral cavity, probiotic bacteria are subjected to saliva, which contains
lysozyme as well as electrolytes; consequently, lysozyme tolerance is one of the criteria
that is used in the selection process for probiotic bacteria. Lysozyme is an antibacterial
enzyme that may be found in tears, egg white, human milk, neutrophil granules, and
saliva, as well as mucus and mucus membranes. Lysozyme can cause damage to the
bacterial cell wall in certain bacteria. When compared to Gram-negative bacteria, Grampositive bacteria are more prone to the hydrolysis process induced by lysozyme. The
initial average growth of each of the isolates was 8.3 Log10 CFU/ml, and after 90
minutes of incubation with lysozyme, it was 8.4 Log10 CFU/ml. All of the isolates
exhibited good tolerance to lysozyme, as shown in Table 4. Other authors have noted
that Lactobacillus strains are able to withstand concentrations of lysozyme with a high
level of resistance and our findings are comparable to those observed from isolates
derived from fermented idli, Rabaadi, pickles, camel milk, and sausages (Yadav et al.,
2016; Abushelaibi et al., 2017; Jia et al., 2021). Studies suggest that the presence of
peptidoglycan in probiotics can be a reason for the resistance of the lysozyme
(Ferraboschi et al., 2021).
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Table 4: Lysozyme tolerance (Log10 CFU/mL) of LAB isolated from vegetables at 0
and 90min
Lysozyme tolerance
Isolates
E. faecium MW721241
E. durans MW721242
E. lactis MW721243
E. faecium MW721244
E. faecium MW721245
E. faecium MW721246
P. acidilactici MW721247
E. durans MW721248
E. faecium MW721249
E. durans MW721250
P. acidilactici MW721251
E. faecium MW721252
E. faecium MW721253
E. durans MW721254
E. durans MW721255
E. durans MW721256
E. faecalis MW721257
a–d
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0 min
8.1±0.47c
8.1±0.45c
8.8±0.57a
8.5±0.49b
8.5±0.31b
8.1±0.35c
8.0±0.43c
8.8±0.36a
8.1±0.59c
8.8±0.40a
8.0±0.52c
8.6±0.27ab
8.4±0.33bc
8.4±0.32bc
8.4±0.33bc
8.5±0.46b
8.4±0.37bc

90 min
8.3±0.27bc
8.1±0.04d
8.4±0.49b
8.2±0.25c
8.3±0.34bc
8.2±0.32c
8.2±0.27c
8.2±0.25c
8.3±0.25bc
8.4±0.32b
8.5±0.47a
8.2±0.23c
8.3±0.29bc
8.4±0.42b
8.4±0.31b
8.3±0.35bc
8.6±0.45a

Mean values in the same column with different lowercases differ significantly (p < 0.05).

4.2 Auto-Aggregation, Co-Aggregation, Hydrophobicity, Adhesion to HT-29 Cells,
and Cholesterol-Lowering
4.2.1 Auto Aggregation
Auto-aggregation is a desirable trait for probiotic strains since it is thought to aid
the colonization of the human gut, prevent pathogen infections, and alter the mucosa of
the colon. When choosing a probiotic bacterium, the ability to adhere to the digestive
tract walls is critical.
Table 5 shows that after 4 hours, the auto-aggregation of the isolates varied from
1.8 to 26.2%; after 24 hours, it rose considerably (p < 0.05) from 42.4 to 73.2%, with an
average of 59.6%, with a smaller difference than after 4 hours. These findings are greater
than some of the probiotic’s studies (Abushelaibi et al., 2017; Vasiee, 2020) but were
lower than that of L. plantarum and Pediococcus pentosaceus (Gao et al., 2021; Sui et
al., 2021). The production of biofilms, which prevent pathogens from attaching to the
gut, is indicated by auto-aggregation and improves gut colonization and the effectiveness
of other probiotics (Gao et al., 2021; Ladha & Jeevaratnam, 2018).
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Table 5: Auto-aggregation (%) of potential probiotic LAB isolates at 4h and 24h
Auto-aggregation (%)
4h
26.1±0.87a
9.8±2.27d
15.6±1.90c
26.2±0.02a
18.9±0.31b
17.4±0.58b
2.0±0.16h
3.8±1.15f
2.3±1.06g
3.6±0.30f
1.8±0.13h
2.4±0.16g
8.2±0.34d
8.0±0.53e
11.1±1.04c
9.4±1.91d

Isolate
E. faecium MW721241
E. durans MW721242
E. lactis MW721243
E. faecium MW721244
E. faecium MW721245
E. faecium MW721246
P. acidilactici MW721247
E. durans MW721248
E. faecium MW721249
E. durans MW721250
P. acidilactici MW721251
E. faecium MW721252
E. faecium MW721253
E. durans MW721254
E. durans MW721255
E. durans MW721256
E. faecalis MW721257

-

24 h
66.5±2.83c
63.6±2.57d
45.0±2.19f
56.7±0.13e
47.2±0.60f
42.9±0.29g
70.3±0.84b
73.2±2.90a
63.6±1.44d
70.6±2.61b
70.5±1.99b
72.0±1.17a
70.5±2.73b
63.4±1.02d
35.2±0.35h
42.4±1.61g
-

Values are the mean ± standard deviation of triplicates. a–h Mean values in the same column with
different lowercases differ significantly (p < 0.05).
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4.2.2 Hydrophobicity
The hydrophobicity of the cell surface of the investigated strains varied greatly,
with the hydrophobic spectrum ranging from 6.9% to 77.1, 17.3% to 86.7%, and 29.3%
to 84.3% for xylene, octane, and hexadecane, respectively (Table 6). E. durans
MW721250 and E. durans MW721254 had the lowest hydrophobicity for all
hydrocarbons. The fact that various hydrocarbons have varied hydrophobicity patterns
demonstrates that hydrophobicity is linked to strain-specific cell surface proteins. The
hydrophobic components of the outer membrane are responsible for this capacity
(Vasiee, 2020; Gao, 2021). In adhesion and biofilm development, bacteria's hydrophobic
contacts are crucial. The content of the surrounding media, the stage of bacteria's
development, and the shape of cell surface components all affect how bacteria behave as
hydrophobic particles (Rokana et al., 2018). The findings were better than those reported
in investigations on isolates from dairy, sausages, and other sources (Ayyash et al.,
2018b; Gao et al., 2021; Reuben et al., 2020). When tested with n-hexadecane alone,
however, P. pentosaceus and Latilactobacillus sakei demonstrated better hydrophobicity
(Ladha & Jeevaratnam, 2018; Sharma et al., 2021) showed lactic acid bacteria isolated
from camel milk had hydrophobicity > 95% to various hydrocarbons.
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Table 6: Hydrophobicity (%) of potential probiotic LAB isolates
Isolate
E. faecium MW721241
E. durans MW721242
E. lactis MW721243
E. faecium MW721244
E. faecium MW721245
E. faecium MW721246
P. acidilactici MW721247
E. durans MW721248
E. faecium MW721249
E. durans MW721250
P. acidilactici MW721251
E. faecium MW721252
E. faecium MW721253
E. durans MW721254
E. durans MW721255
E. durans MW721256
E. faecalis MW721257

Hydrophobicity (%)
Xylene
Octane
61.4±3.07b
68.7±2.06c
35.9±1.79cd
40.7±1.22de
a
77.1±3.86
79.0±2.37b
a
71.0±3.55
86.7±2.60a
66.0±3.30b
79.0±2.37b
bc
56.9±2.84
69.4±2.08c
f
13.3±0.66
36.6±1.10de
d
32.7±1.64
38.3±1.15de
f
13.7±0.69
28.6±0.86e
f
13.0±0.65
17.3±0.52g
11.4±0.57g
29.9±0.90e
e
18.9±0.94
23.7±0.71ef
cd
33.4±1.67
21.7±0.65f
h
6.9±0.34
30.3±0.91e
cd
34.0±1.70
44.6±1.34d
c
40.1±2.01
56.1±1.68cd
31.0±1.55d
45.7±1.37d

Hexadecane
76.1±3.05b
47.3±1.89c
84.3±3.37a
82.0±3.28ab
80.7±3.23b
73.3±2.93bc
39.6±1.58d
45.7±1.83c
32.1±1.29e
29.3±1.17f
34.9±1.39de
42.3±1.69c
34.1±1.37de
35.3±1.41de
30.7±1.23e
46.9±1.87c
39.9±1.59d

Values are the mean ± standard deviation of triplicates. a–f Mean values in the same column with different
lowercases differ significantly (p < 0.05).
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4.2.3 Attachment to HT-29 Cells
The potential of probiotics is linked to their ability to survive in the
gastrointestinal system. As a result, attachment ability is used as a criterion for choosing
a suitable probiotic. The interaction of lipids, peptidoglycan, and surface proteins on the
bacterial cell wall is involved in the attachment. Many Lactobacillus species have been
shown to have protein elements connected to their cell walls that facilitate bacterial
attachment to intestinal epithelial cells.
After allowing isolates to attach to HT-29 cells for 2 hours, they displayed similar
attachment capacities, with an average of 8.03 Log10 CFU/mL. The growth rate varied
between 7.5 and 8.3 Log10 CFU/mL. (Table 7). These findings are in agreement with
those of (Oh & Jung, 2015; Vasiee, 2020; Gao, 2021), who recovered Lactobacillus,
Pediococcus, and Lactiplantibacillus bacteria from kimchi, alcoholic drinks, and other
sources, but the camel milk isolates from (Sharma et al., 2021) showed 99% attachment
ability which is much better than our findings. The ability of probiotics to adhere to
epithelial cells is thought to be strain dependent as well as different cell lines showed
different attachment properties; hence the rates of adhesion vary between isolates (Oh &
Jung, 2015; Domingos‐Lopes et al., 2020).
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Table 7: Attachment to HT-29 cells (Log10 CFU/well) of potential probiotic LAB
isolates
Isolate
E. faecium MW721241
E. durans MW721242
E. lactis MW721243
E. faecium MW721244
E. faecium MW721245
E. faecium MW721246
P. acidilactici MW721247
E. durans MW721248
E. faecium MW721249
E. durans MW721250
P. acidilactici MW721251
E. faecium MW721252
E. faecium MW721253
E. durans MW721254
E. durans MW721255
E. durans MW721256
E. faecalis MW721257

Attach to HT-29
Log10 CFU
8.0±0.08c
8.0±0.00c
8.1±0.02b
8.0±0.10c
8.1±0.07b
8.1±0.04b
8.1±0.04b
8.1±0.03b
8.1±0.04b
7.9±0.03d
8.0±0.07c
8.1±0.06b
8.0±0.05c
7.5±0.01d
8.0±0.05c
8.1±0.02b
8.3±0.08a

Values are the mean ± standard deviation of triplicates. a–d Mean values in the same column with
different lowercases differ significantly (p < 0.05).
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4.2.4 Co-Aggregation
Coaggregation plays a significant role in the elimination of pathogens from the
gastrointestinal system. The coaggregation of different strains of Lactobacillus has the
potential to create a barrier that impedes the colonization of harmful bacteria. Table 8
presents the findings of a co-aggregation test conducted against four well-known
foodborne pathogens (E. coli O157:H7, S. Typhimurium, L. monocytogenes, and S.
aureus) while the bacteria were incubated at 37°C for 4 and 24 hours. As observed in
Table 8A, after 4 hours, the co-aggregation rates ranged from a low of 3.44% to a high
of 10.43%, but after 24 hours, as shown in Table 8B, the range increased to a high of
21.38%to 42.61%. This indicates that the ability to co-aggregate is directly correlated
with the passage of time (Abushelaibi, 2017). After 24 hours, the coaggregation rates of
E. faecium MW721252 with all pathogens were the highest, followed by E. durans
MW721255, which had the lowest rate (Table 8B). The results of the analysis of
variance did not show any significant differences in the co-aggregation of the four
foodborne pathogens when they were found in the same isolate at the same time. Our
results show lesser coaggregation than isolates obtained from raw milk and rumen liquor
of goats, but similar results to that of probiotics obtained from sausages and dairy
products reported (AlKalbani et al., 2019; Ladha & Jeevaratnam, 2018; Tatsaporn &
Kornkanok, 2020). The capacity of the probiotic strains to co-aggregate is one of the
most important factors in biofilm formation and the competition with pathogens for
binding sites and is considered an essential characteristic of probiotics.
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Table 8A: Coaggregation (%) of LAB isolates with four pathogens after 4h
Isolates
E. faecium MW721241
E. durans MW721242
E. lactis MW721243
E. faecium MW721244
E. faecium MW721245
E. faecium MW721246
P. acidilactici MW721247
E. durans MW721248
E. faecium MW721249
E. durans MW721250
P. acidilactici MW721251
E. faecium MW721252
E. faecium MW721253
E. durans MW721254
E. durans MW721255
E. durans MW721256
E. faecalis MW721257

E. coli
10.1±0.50a
7.6±0.38c
9.4±0.47ab
6.8±0.34ed
8.4±0.42b
7.8±0.39c
5.5±0.27d
4.0±0.20e
4.1±0.21e
4.9±0.25e
3.2±0.16f
2.9±0.15g
3.4±0.17f
5.7±0.28d
5.7±0.28d
5.1±0.26de

S. Typhi
10.6±0.63a
8.4±0.51bc
6.7±0.40d
9.6±0.58b
9.4±0.57b
5.9±0.35e
3.8±0.23g
6.7±0.40d
5.5±0.33e
7.7±0.46c
4.4±0.26f
5.5±0.33e
6.1±0.37d
7.7±0.46c
6.4±0.38d
5.2±0.31e

4h
S. aureus
10.0±0.70a
9.7±0.68b
10.0±0.70a
9.3±0.65b
10.8±0.76a
8.2±0.58c
4.4±0.31d
6.3±0.44de
5.1±0.36e
4.9±0.34f
3.2±0.23g
4.7±0.33g
9.1±0.64b
7.1±0.50cd
7.5±0.53cd
7.0±0.49d

L. monocytogenes
10.2±0.71a
8.0±0.56b
6.8±0.47d
10.3±0.72a
8.7±0.61b
6.7±0.47d
3.9±0.27f
6.1±0.43d
3.8±0.27f
6.2±0.43d
5.1±0.36e
3.9±0.27f
5.7±0.40e
6.7±0.47d
7.1±0.49c
6.1±0.43d

Values are the mean ± standard deviation of triplicates. a–g Mean values in the same column with
different lowercases differ significantly (p < 0.05)

Table 8B: Coaggregation (%) of LAB isolates with four pathogens after 24h
Isolates
E. faecium MW721241
E. durans MW721242
E. lactis MW721243
E. faecium MW721244
E. faecium MW721245
E. faecium MW721246
P. acidilactici MW721247
E. durans MW721248
E. faecium MW721249
E. durans MW721250
P. acidilactici MW721251
E. faecium MW721252
E. faecium MW721253
E. durans MW721254
E. durans MW721255
E. durans MW721256
E. faecalis MW721257

E. coli
25.5±1.78d
23.8±1.67d
21.7±1.52e
22.1±1.55e
22.4±1.57e
20.5±1.44e
38.6±2.70b
43.8±3.07a
33.7±2.36c
43.5±3.05a
42.4±2.97a
45.5±3.18a
30.5±2.14c
26.6±1.86d
18.2±1.28f
21.5±1.50e

S. Typhi
32.7±1.31b
24.4±0.98c
23.8±0.95cd
28.0±1.12bc
26.7±1.07c
22.5±0.90d
40.0±1.60
40.8±1.63b
42.3±1.69aa
39.1±1.56ab
33.8±1.35b
40.7±1.63ab
24.2±0.97c
25.7±1.03c
21.0±0.84d
22.7±0.91d

24h
S. aureus
34.8±0.70d
27.1±0.54e
27.4±0.55e
31.3±0.63d
30.7±0.61d
29.7±0.59e
38.6±0.77b
39.2±0.78b
44.0±0.88a
39.4±0.79b
37.4±0.75c
40.7±0.81b
27.4±0.55
28.5±0.57e
25.2±0.50f
27.8±0.56e

L. monocytogenes
32.6±1.63b
25.0±1.25de
23.9±1.19de
28.6±1.43c
26.2±1.31d
24.8±1.24de
35.6±1.78b
28.0±1.40c
36.6±1.83ab
38.7±1.94a
31.8±1.59b
36.7±1.83ab
26.4±1.32d
26.5±1.32d
21.2±1.06e
21.1±1.05e

Values are the mean ± standard deviation of triplicates. a–f Mean values in the same column with
different lowercases differ significantly (p < 0.05)
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4.2.5 Cholesterol Removal
The deconjugation of bile salts by the enzyme bile salt hydrolase (BSH), the
production of short-chain fatty acids, the assimilation of cholesterol into bacterial cell
membranes, and the conversion of cholesterol by hydrogenation to the poorly absorbed
sterol coprostanol have all been demonstrated as mechanisms for cholesterol removal by
probiotics (Hernández-Gómez et al., 2021). From Table 9, it is seen that all the isolates
have the ability to reduce the cholesterol in the broth, and the reduction percentage
ranged from 17% to 35%, and E. faecium MW721241, E.lactis MW721243, P.
acidilactici MW721247, E. faecium MW721249, E. faecium MW721252, E. faecium
MW721253, E. durans MW721254, and E. faecalis MW721257 showed reduction more
than 30%, which coincided with the lactic acid bacteria isolated from traditional Italian
cheeses (Albano et al., 2018). Several studies showed the reducing potential of
cholesterol using LAB and its role in controlling hypercholesterolemia (Albano et al.,
2018; Tsai et al., 2014).
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Table 9: Cholesterol removal (%) ability of LAB isolates
Isolate
E. faecium MW721241
E. durans MW721242
E. lactis MW721243
E. faecium MW721244
E. faecium MW721245
E. faecium MW721246
P. acidilactici MW721247
E. durans MW721248
E. faecium MW721249
E. durans MW721250
P. acidilactici MW721251
E. faecium MW721252
E. faecium MW721253
E. durans MW721254
E. durans MW721255
E. durans MW721256
E. faecalis MW721257

CR (%)
35.0±1.41a
27.5±2.12e
34.5±0.71a
17.5±0.71g
17.0±1.41g
29.5±0.71d
30.0±0.23c
33.0±1.41b
30.5±3.54c
24.5±2.12f
29.0±0.99d
30.0±2.83c
35.0±0.98a
30.0±2.83c
27.5±2.12e
24.5±2.12f
30.0±2.83c

Values are the mean ± standard deviation of triplicates. a–g Mean values in the same column with
different lowercases differ significantly (p < 0.05)
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4.3 Clinical and Industrial Benefits (Bile Salt Hydrolase, Antimicrobials, and
Exopolysaccharides (EPS)), Immunomodulatory Effects and Susceptibility to
Antibiotics
4.3.1 Bile Salt Hydrolase (BSH) Activity
Bile salt hydrolase is an enzyme that probiotic bacteria can produce to hydrolyze
conjugated bile salts, and these deconjugated bile salts or acids trigger the removal of
cholesterol by helping in the absorption of cholesterol into the human gut. Deconjugated
bile salts consequently co-precipitate with cholesterol and damage its solubility, resulting
in the ejection of cholesterol in the stool (Begley et al., 2006). Deconjugation is a
gateway reaction in the metabolism of bile acids in the small intestine, which overall
impacts in reduction of the blood cholesterol level in the individual with
hypercholesterolemia (Hernández-Gómez et al., 2021; Xu et al., 2019). Table 10 shows
that nearly all the LAB showed the ability to hydrolyze the bile salts mixture by
releasing the amino acids in the medium. As shown in Table 10, E. faecium MW721249
and Enterococcus durans MW721254 had the lowest activity compared to E. lactis
MW721243 and E. faecium MW721244 which had the highest. BSH activity plays a
significant role in inhibiting cholesterol absorption/uptake in the human intestine. The
ability to hydrolyze bile salt leads to disrupting the formation of the cholesterol micelle
in the human intestine (Abdalla et al., 2021). Our BSH with those reported by (Ayyash et
al., 2018a; Tarique et al., 2022). BSH activity, along with cholesterol removal, has
become one of the criteria for probiotics (Amiri et al., 2020).
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Table 10: Bile salt hydrolysis activity (U/mg) of LAB isolates
Isolate
E. faecium MW721241
E. durans MW721242
E. lactis MW721243
E. faecium MW721244
E. faecium MW721245
E. faecium MW721246
P. acidilactici MW721247
E. durans MW721248
E. faecium MW721249
E. durans MW721250
P. acidilactici MW721251
E. faecium MW721252
E. faecium MW721253
E. durans MW721254
E. durans MW721255
E. durans MW721256
E. faecalis MW721257

BSH(U/mg)
0.83±0.03f
0.95±0.05b
1.03±0.07a
1.00±0.08a
0.93±0.05b
0.83±0.03f
0.91±0.06c
0.87±0.07d
0.80±0.02g
0.84±0.04e
0.84±0.04e
0.84±0.05e
0.82±0.04f
0.80±0.03g
0.81±0.06g
0.97±0.04ab
0.91±0.07c

Values are the mean ± standard deviation of triplicates. a–g Mean values in the same column with
different lowercases differ significantly (p < 0.05)
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4.3.2 Antimicrobial Activities
One of the most remarkable effects that have been observed is the antimicrobial
activity against various pathogens. To be taken into consideration for the selection of
potential probiotic strains. LAB isolates exhibited a wide range of inhibitory levels
against all of the foodborne pathogens tested, despite having a relatively broad spectrum
of activity. Lactic Acid Bacteria have the ability to produce antimicrobial compounds
such as organic acids, diacetyl, hydrogen peroxide, ethanol, reuterin, bacteriocins, and
proteins that kill bacteria. It has been discovered that LABs are able to inhibit
microorganisms that cause spoilage and pathogens by producing anti-microbial
metabolites. According to the work that was done, it would appear that the antimicrobial
activities of all of the isolated LAB resulted not from the acidity of the crude extracts but
rather from the active compounds that were produced by the probiotics, as noticed in
Table 11B, postbiotic, which are heat-killed bacteria, had a better antimicrobial effect
against E. coli than probiotics, while probiotics Table 11A had a better effect against S.
aureus and L. monocytogenes when compared with postbiotic. It has been reported that
metabolites produced by LAB isolates, such as bacteriocins, peptides, organic acids, and
volatile compounds, are highly associated with antimicrobial activity (Abushelaibi,
2017; Reuben, 2020; Vasiee, 2020). The antimicrobial activity of the killed cells
suggests that the cell membrane and cytoplasm possess antimicrobial activities against
foodborne pathogens. Our results coincide with those reported by (Miremadi et al.,
2014).

49

Table 11A: Antimicrobial activity of potential probiotics (live bacteria) LAB isolates
against four foodborne pathogens
Isolates
E. faecium MW721241
E. durans MW721242
E. lactis MW721243
E. faecium MW721244
E. faecium MW721245
E. faecium MW721246
P. acidilactici MW721247
E. durans MW721248
E. faecium MW721249
E. durans MW721250
P. acidilactici MW721251
E. faecium MW721252
E. faecium MW721253
E. durans MW721254
E. durans MW721255
E. durans MW721256
E. faecalis MW721257

E. coli
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

Probiotic a
S. aureus
S. Typhi
++
+++
++
++
++
++
+++
+++
+++
+++
++
+++
+++
+++
+++
+++
++
++
++
++
++
++
+++
++
++
++
+
+
++
+
+
++
++
++

L. monocytogenes
+++
+++
++
+++
+++
+++
+++
++
++
++
+++
++
++
+
+
+
+

(+) log reduction was <1.0; (++) log reduction was less than 2.0 and higher than 1.0; (+++) log
reduction was greater than 2.1
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Table 11B: Antimicrobial activity of potential postbiotics (heat killed bacteria) LAB
isolates against four foodborne pathogens
Isolates
E. faecium MW721241
E. durans MW721242
E. lactis MW721243
E. faecium MW721244
E. faecium MW721245
E. faecium MW721246
P. acidilactici MW721247
E. durans MW721248
E. faecium MW721249
E. durans MW721250
P. acidilactici MW721251
E. faecium MW721252
E. faecium MW721253
E. durans MW721254
E. durans MW721255
E. durans MW721256
E. faecalis MW721257

E. coli
+++
++
++
++
+
++
++
++
++
++
++
++
+
+
+
+
+

Postbiotic b
S. aureus
S. Typhi
+++
+++
++
++
++
++
++
++
+
+
++
++
++
++
++
++
++
++
++
++
++
++
++
++
+
+
+
+
+
+
+
+
+
+

L. monocytogenes
+++
++
++
++
+
++
++
++
++
++
++
++
+
+
+
+
+

(+) log reduction was <1.0; (++) log reduction was less than 2.0 and higher than 1.0; (+++) log
reduction was greater than 2.1
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4.3.3 Antibiotic Resistance
In order to be considered probiotics, microbial strains should not serve as a
reservoir for antibiotic resistance genes, as these genes could potentially be passed on to
intestinal pathogens via transposons and plasmids (Goh et al., 2021). Table 12 presents
the findings regarding the levels of antibiotic resistance and susceptibility discovered
throughout the course of this investigation. However, the majority of probiotic bacteria
were either susceptible to the majority of antibiotics or were only moderately susceptible
but were resistant to the vancomycin, as it’s known that most of the Lactobacillus strains
are resistant naturally to some of the antibiotics (Wong et al., 2015). Some other studies
showed similar behavior where they found the probiotics were either resistant or
partially susceptible, which suggests that it can be used in combination with antibiotics
for the treatment of certain infections (Neut et al., 2017). Because there is a risk that
antibiotic-resistant bacteria could be horizontally transmitted to non-resistant bacteria,
including pathogens, the antibiotic resistance of potential probiotic bacteria is an
important safety consideration when selecting these bacteria for use as probiotic
organisms and starter culture (Vieco-Saiz et al., 2019).
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Table 12: Antibiotics susceptibility of LAB isolated from vegetables
Isolates
E. faecium MW721241
E. durans MW721242
E. lactis MW721243
E. faecium MW721244
E. faecium MW721245
E. faecium MW721246
P. acidilactici MW721247
E. durans MW721248
E. faecium MW721249
E. durans MW721250
P. acidilactici MW721251
E. faecium MW721252
E. faecium MW721253
E. durans MW721254
E. durans MW721255
E. durans MW721256
E. faecalis MW721257

Vancomycin
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R

Antibiotics susceptibility
Erythromycin Penicillin
S
S
S
S
R
S
MS
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
MS
S
MS
MS
S
S
S
S
S
S
S
S

Clindamycin
S
S
R
R
MS
R
S
S
S
S
S
S
MS
S
MS
S
S

R = resistant; MS = moderately resistant; S = susceptible.
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4.3.4 EPS Production
Fermented foods, which are associated with probiotic microorganisms, create
substances that are significant from a technological perspective, such as
exopolysaccharides (EPS). EPS are extracellular macromolecules that are excreted by
microorganisms either in the form of a tightly bound capsule or a loosely attached slime
layer (Angelin & Kavitha, 2020; Tarique et al., 2022). Desiccation, phagocytosis, cell
recognition, phage attack, antibiotics or toxic compounds, and osmotic stress are some of
the things that they are most effective at defending against (Angelin & Kavitha, 2020).
Table 13 provides a summary of the findings from the production of exopolysaccharides
(EPS). E. faecium MW721241, E. durans MW721242, P. acidilactici MW721247, E.
durans MW721248, E. durans MW721250, E. durans MW721256, and E. faecalis
MW721257 did not demonstrate the ability to produce EPS, whereas the remaining
demonstrated the ability to produce EPS. EPS can be produced in bacteria either freely in
the medium or in the form of capsules. Nevertheless, EPSs have been shown to have a
significant correlation with the formation of biofilms, attachment to the intestinal cell
wall, reduction in cholesterol levels, and protection against harsh environmental
conditions (Abdalla et al., 2021). In comparison to other naturally occurring agents,
exopolysaccharides that are produced by microorganisms offer a number of advantages,
both in terms of their potential for use in industrial and therapeutic applications (Angelin
& Kavitha, 2020). EPS obtained from lactic acid bacteria possess remarkable and
valuable properties that can be used in place of polysaccharides derived from either
plants or animals.
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Table 13: EPS production of LAB isolated from vegetables
Isolate
E. faecium MW721241
E. durans MW721242
E. lactis MW721243
E. faecium MW721244
E. faecium MW721245
E. faecium MW721246
P. acidilactici MW721247
E. durans MW721248
E. faecium MW721249
E. durans MW721250
P. acidilactici MW721251
E. faecium MW721252
E. faecium MW721253
E. durans MW721254
E. durans MW721255
E. durans MW721256
E. faecalis MW721257

EPS production
+
+
+
+
+
+
+
+
+
-

(-) EPS negatives; (+) EPS positive
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4.3.5 Immunomodulatory Effect
The literature provides a detailed account of the interaction that occurs between
the microbiota in the gut and the immune system. Probiotics have been shown to have
anti-allergic properties in a number of studies, primarily through the induction of a
predominant Th1 cytokine response (Ai et al., 2016; Vinderola et al., 2005; Cuffia et al.,
2019). One of these studies claimed that probiotics could lessen the damage that is
caused by allergic reactions to the host and identified three types of lactic acid bacteria
(La, Lp, and Lc) that have these characteristics (Ai et al., 2016). In light of the findings
we've obtained thus far, the potential probiotics E. lactis MW721243 and P. acidilactici
MW721251 have been chosen for additional immunological investigation.
The capability of E. lactis MW721243 and P. acidilactici MW721251 as
probiotics (live bacteria) and postbiotics (killed bacteria) to induce the secretion of IFNand IL-4 cytokines in ex vivo cultured murine spleen cells was used to evaluate the
immunomodulatory effects of these two strains of bacteria as probiotics and postbiotics,
respectively. These studies were conducted using spleen cells obtained from two
different inbred mouse strains, namely C57BL/6 and BALB/c mice, which are
genetically distinct from one another (Figure 2). This was done so that the
immunological profiles of the LAB strains would be applicable across a wide variety of
host genetic backgrounds (Mills et al., 2000). The findings show that E. lactis
MW721243 and P. acidilactici MW721251 were responsible for stimulating the
production of IFN-g by spleen cells (Figure 1A-D). The fact that the higher LAB
concentration of 107/ml was toxic to splenocytes most likely explains why the detectable
IFN-g levels were higher when E. lactis MW721243 and P. acidilactici MW721251
were used at the 106/ml concentration. In addition, when the E. lactis MW721243 was
used as a postbiotic (a preparation in which the bacteria have been killed) rather than a
probiotic (live bacteria), a significantly higher amount of IFN- was secreted (Figure 2A,
C). In contrast, the use of P. acidilactici MW721251 as a probiotic consistently resulted
in higher levels of IFN- production, and this was true regardless of the mouse strain
(Figure 2B, D). In addition, there was no discernible increase in the amount of IL-4 that
was produced by spleen cells when they were cultured with either LAB strain (Figure
2E-H). It is interesting to note that both E. lactis MW721243 and P. acidilactici
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MW721251 appear to induce higher levels of IFN- production by BALB/c splenocytes
compared to C57BL/6 cells. This finding highlights the powerful pro-Th1-inducing
capacity of both isolates. Given what is already known about the tendency of BALB/c
mice to develop Th2 immune responses, this is a striking finding (Mills et al., 2000).
These findings demonstrate that E. lactis MW721243 and P. acidilactici MW721251 are
capable of inducing IFN- production in spleen cells that have been cultured in vitro,
which suggests that they have the potential to inhibit Th2 responses in vivo. These
findings need to be confirmed in additional experiments before they can be applied to a
preclinical allergy model.
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Figure 2: Immunomodulatory effect of two potential probiotics (live, red bar) and
postbiotics (killed, blue bar) of E. lactis MW721243 (A,C,E,G) and P. acidilactici
MW721251 (B,D,F,H) isolates against spleen cells C57BL/6 and BALB/c. where (A)
and (B) are IFN-𝛾 response of C57BL/6, (E) and (F) are IFN-𝛾 response of BALB/c, (C)
and (D) are IL-4 response of C57BL/6, (G) and (H) IL-4 response of BALB/c against
MBL3 and MBL10, respectively. Asterisks denote statistical significantly differences
between the indicated groups and the corresponding control groups.
(*p <0.05; **p<0.01; ***p<0.001; **** p < 0.0001).
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Chapter 5: Conclusions, Limitation, and Future Directions
Vegetables were used as a source to isolate Lactic Acid Bacteria with desirable
probiotic characteristics. This study chose fresh fruits and vegetables due to their low
sugar content, enrich mineral and vitamin content, and neutral pH that enhanced the
process of LAB fermentation. In addition, consuming LAB fermented fruits and
vegetables provided healthy balanced diet in terms of vitamins, minerals and
carbohydrates content which played a significant role in the reduction of diarrhea and
liver cirrhosis. Moreover, the colored pigments found in several fruits and vegetables
acts a antioxidant that fights free radicals which reduce the risk of several diseases
including cancer, arthritis, and ageing.
In terms of result of the tests performed in this study, almost all the isolates were
able to tolerate simulated oral, gastric, and intestinal conditions. They also showed
resistance to bile and lysozyme, reduced cholesterol in the media, and showed
outstanding adhesion to the intestine, which includes hydrophobicity study on
hydrocolloids, auto-aggregation, co-aggregation, attachment to HT-29 cells, and some
selected isolates showed promising immunomodulatory effects. Moreover, the selected
isolates displayed antimicrobial and bile salt hydrolysis activity and were susceptible to
antibiotics which erases the concern for the gene transfer in the non-resistant pathogens.
However, EPS was produced by all isolates except E. faecium MW721241, E. durans
MW721242, P. acidilactici MW721247, E. durans MW721248, E. durans MW721250,
E. durans MW721256, and E. faecalis MW721257. All 17 isolates belonged to
Enterococcus faecium, Enterococcus durans, Enterococcus lactis, Pediococcus
acidilactici, and Enterococcus faecalis. The isolates showed exceptional probiotics
properties in vitro and can be used to exploit industrial and clinical purposes. Regarding
the limitations of this study, the hemolytic activity of the selected LAB isolates was not
performed. Further studies are required to test whether the new probiotics discovered
exhibited any of antimicrobial, anticancer, antihypertensive, and antioxidant features. In
addition, more investigation is needed to identify the industrial properties of these new
isolates.
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Tejero-Sariñena, S., Barlow, J., Costabile, A., Gibson, G. R., & Rowland, I. (2012). In
vitro evaluation of the antimicrobial activity of a range of probiotics against
pathogens: Evidence for the effects of organic acids. Anaerobe, 18(5), 530-538.
Teuber, M. (2001). Lactic Acid Bacteria. Wiley Press.
Tindall, B. J. (2008). The type strain of Lactobacillus casei is atcc 393, atcc 334 cannot
serve as the type because it represents a different taxon, the name Lactobacillus
paracasei and its subspecies names are not rejected and the revival of the name
'Lactobacillus zeae' cont. International Journal of Systematic and Evolutionary
Microbiology, 58(7), 1764-1765.
Tsai, C.C., Lin, P.P., Hsieh, Y.M., Zhang, Z., Wu, H.C., & Huang, C.C. (2014).
Cholesterol-Lowering Potentials of Lactic Acid Bacteria Based on Bile-Salt
Hydrolase Activity and Effect of Potent Strains on Cholesterol Metabolism In Vitro
and In Vivo. The Scientific World Journal, 2014, 1–10.
Tsilingiri, K., & Rescigno, M. (2013). Postbiotics: what else?. Beneficial Microbes, 4(1),
101-107.
Tuo, Y., Yu, H., Ai, L., Wu, Z., Guo, B., & Chen, W. (2013). Aggregation and adhesion
properties of 22 Lactobacillus strains. Journal of Dairy Science, 96(7), 4252–4257.
Vasiee, A. (2020). Probiotic characterization of Pediococcus strains isolated from Iranian
cereal-dairy fermented product: Interaction with pathogenic bacteria and the enteric
cell line Caco-2. Journal of Bioscience Bioengineering, 130, 29-43.
Ventura, M., van Sinderen, D., Fitzgerald, G. F., & Zink, R. (2004). Insights into the
taxonomy, genetics and physiology of bifidobacteria. Antonie Van Leeuwenhoek,
86(3), 205-223.
Vidhyasagar, V., & Jeevaratnam, K. (2013). Evaluation of Pediococcus pentosaceus
strains isolated from idly batter for probiotic properties in vitro. Journal of
Functional Foods, 5(1), 235-243.
Vieco-Saiz, N., Belguesmia, Y., Raspoet, R., Auclair, E., Gancel, F., Kempf, I., &
Drider, D. (2019). Benefits and inputs from lactic acid bacteria and their bacteriocins
as alternatives to antibiotic growth promoters during food-animal production.
Frontiers in microbiology, 10, 57-68.
Vinderola, C. G., Duarte, J., Thangavel, D., Perdigón, G., Farnworth, E., & Matar, C.
(2005). Immunomodulating capacity of kefir. Journal of Dairy Research, 72(2), 195–
202.

75

Wang, Z., Cui, Y., Liu, P., Zhao, Y., Wang, L., Liu, Y., & Xie, J. (2017). Small peptides
isolated from enzymatic hydrolyzate of fermented soybean meal promote
endothelium-independent vasorelaxation and ACE inhibition. Journal of Agricultural
and Food Chemistry, 65(50), 10844-10850.
Wong, A., Ngu, D. Y. S., Dan, L. A., Ooi, A., & Lim, R. L. H. (2015). Detection of
antibiotic resistance in probiotics of dietary supplements. Nutrition Journal, 14(1),
95. https://doi.org/10.1186/s12937-015-0084-2
Xu, F., Hu, X.J., Singh, W., Geng, W., Tikhonova, I. G., & Lin, J. (2019). The complex
structure of bile salt hydrolase from Lactobacillus salivarius reveals the structural
basis of substrate specificity. Scientific Reports, 9(1), 1243.
https://doi.org/10.1038/s41598-019-48850-6
Yadav, R., Puniya, A. K., & Shukla, P. (2016). Probiotic Properties of Lactobacillus
plantarum RYPR1 from an Indigenous Fermented Beverage Raabadi. Frontiers in
Microbiology, 7. https://doi.org/10.3389/fmicb.2016.01683
Yang, X., Zhou, J., Fan, L. (2018). Antioxidant properties of a vegetable–fruit beverage
fermented with two Lactobacillus plantarum strains. Food Sci Biotechnol, 27, 1719–
1726.
Yasmin, I., Saeed, M., Khan, W. A., Khaliq, A., Chughtai, M. F. J., Iqbal, R., ... &
Tanweer, S. (2020). In vitro probiotic potential and safety evaluation (hemolytic,
cytotoxic activity) of Bifidobacterium strains isolated from raw camel milk.
Microorganisms, 8(3), 354-367.
Yerlikaya, O., & Akbulut, N. (2020). In vitro characterisation of probiotic properties of
Enterococcus faecium and Enterococcus durans strains isolated from raw milk and
traditional dairy products. International Journal of Dairy Technology, 73(1), 98–107.
Zannini, E., Waters, D. M., Coffey, A., & Arendt, E. K. (2016). Production, properties,
and industrial food application of lactic acid bacteria-derived exopolysaccharides.
Applied Microbiology and Biotechnology, 100(3), 1121-1135.
Zhang, P., Roytrakul, S., & Sutheerawattananonda, M. (2017). Production and
purification of glucosamine and angiotensin-i converting enzyme (ace) inhibitory
peptides from mushroom hydrolysates. Journal of Functional Foods, 36, 72-83.
Zhong, Z., Zhang, W., Song, Y., Liu, W., Xu, H., Xi, X., . . . Sun, Z. (2017).
Comparative genomic analysis of the genus Enterococcus. Microbiological
Research, 196, 95-105.

76

Zocco, M. A., Dal Verme, L. Z., Cremonini, F., Piscaglia, A. C., Nista, E. C., Candelli,
M., . . . Gasbarrini, A. (2006). Efficacy of Lactobacillus gg in maintaining remission
of ulcerative colitis. Alimentary Pharmacology and Therapeutics, 23(11), 15671574.
Zommiti, M., Feuilloley, M. G., & Connil, N. (2020). Update of probiotics in human
world: a nonstop source of benefactions till the end of time. Microorganisms, 8(12),
1907-1923.
Żółkiewicz J, Marzec A, Ruszczyński M, Feleszko W. (2020). Postbiotics-A Step
Beyond Pre- and Probiotics. Nutrients. 12(8), 2189-2195.
Zuccotti, G., Meneghin, F., Aceti, A., Barone, G., Callegari, M. L., Di Mauro, A., . . .
Corvaglia, L. (2015). Probiotics for prevention of atopic diseases in infants:
Systematic review and meta-analysis. Allergy: European Journal of Allergy and
Clinical Immunology, 70(11), 1356-1371.
Zuo, F., Yu, R., Feng, X., Chen, L., Zeng, Z., Khaskheli, G. B., . . . Chen, S. (2016).
Characterization and in vitro properties of potential probiotic Bifidobacterium strains
isolated from breast-fed infant feces. Annals of Microbiology, 66(3), 1027-1037.

77

List of Publications
Alameri, F., Tarique, M., Osaili, T., Obaid, R., Abdalla, A., Masad, R., Al-Sbiei, A.,
Fernandez-Cabezudo, M., Liu, S. Q., Al-Ramadi, B., & Ayyash*, M. (2022). Lactic
Acid Bacteria Isolated from Fresh Vegetable Products: Potential Probiotic and
Postbiotic Characteristics Including Immunomodulatory Effects. Microorganisms,
10(2), 389-397.

78

UAE UNIVERSITY MASTER THESIS NO. 2022:69
The ability to perform effectively in the gastrointestinal system (GIT) is one of
the most significant criteria for selecting the best probiotic bacteria. Thus, the
present study aimed to investigate the potential probiotic characteristics of some
selected lactic acid bacteria (LAB) isolated from vegetable products.
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